The aging kidney  by Rodrfguez-Puyol, Diego
Kidney IntemazionaL VoL 54 (1998) pp. 224 7-22t55
The aging kidney
Principal discussant: DIEGO RODRiGUEZPUYOL
University Hospital "Prmncipe de .-lsturias' and University of Alcalá, Madrü& Spain
NEPHROLOGY FORUM
CASE PRESENTATION
Patient 1. An 87-year-old woman was admitted to the emergency room
of the AIcalá de Henares Hospital after a fall at home. She had a
long-standing history of hypertension, which was well controlled with
nifedipine and indapamide. A hysterectomy had been performed 30 years
ago. Evaluation at the emergency room revealed a femoral neck fracture,
and she was prepared for an internal fixation under epidural ancsthesia.
Pre-operatoiy evaluation disclosed no significant metabotic alterations,
the plasma creatinine concentration was 1.0 mg/dI with a normal urinal-
ysis, and no significant cardiologic problems were detected. 1'he surgical
procedure took placc without complications, and the patient was treated
with intravenous fluids, analgesics, gentamicin, and cefazolin at standard
doses. Six days after the surgical procedure, a progressive decrease in th
urine volume was detected, and a nephrology consultant was contacted.
A careful analysis of the evolution of the patient's course was unable to
deeci s*gnificant hemodynamic changes after the surgica' procedure, and
moderate fever was detected only on days 2 and 3. On physical examina-
tion, she appeared well, without dyspnea, edcma, or clirncal signs of
volume depletion. A grade Il/VI systolic ejecflon murmur as audible; no
pericardial friction rub was heard. The surgical area appearcd well,
without infection. Neurologic examination was negative; flapping was not
detected. The rcst of the physical examination was unremarkable.
The hematocrit was 28%; hemoglobin. .2 g/dl; white blood cell count,
10,900/mm3. The urea was 143 mg/d; creatinine, 63 rng/dl; sodium, 130
mmol/iitcr potassium, 4.3 mmol/titer; chloride, 107 mmol/Iiter; calcium,
8.7 ing/dI; phosphorus, 5.4 mgldl; albumin, 2.3 g/d!; glucose, lt)7 mg/dI;
arterial blood pH, 7.33; and bicarbonate, 19.2 mmol/titer. The urine was
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2+ for protein and contained S red cells and some granular casts/high-
power field. Fractional excretion of sodium was 2.7%. No cosinophils were
detected in the urine. An ultrasound examination of the abdomen failed to
reveal obstruction of the urinary tract.
Acute tubular necrosis was diagnosed and probably was due to the use
of aminoglycosides. She requircd six hemodialysis sessions. Urine flow
progressively increased and she was dischargcd with a serum creatinine of
2.9 mg/dL Subsequently the serum crcatinine fell to 1.2 mgId, with a
creatinjne clearance of 41 mI/mm.
Patient 2. An 80-ycar-old woman was admitted to the emergency room
of the Alcali de Henares Hospital bccausc of asthenia and muscle
weakness. She had had hypertension for a long time, but her blood
pressure was well controlled with hydruhorothiazide, amiloride, and
captopril. The patient had no signs of rcna disease, and in a recent
examination, thc serum creatinine was 1.3 mg/dI; urea, 68 mg(dl; sodium,
137 mmollhtcr; and potassium, 5.0 mmotlliter. with a normal urinalysis.
Because of generalized articular pain, a general practitioner prescribed
tenoxicam, a nonsterojdal antiinflammatory agent. 10 days before admis-
sion.
Evaluation jt the emergency room showed a mildly obese woman who
appeared ill, with significant muscle weakness and minimal dryness of the
mouth. The heniatocrit was 30.9%; hemoglobin, lO.2fdl; white blood cell
count, 5900/mm3; and platelet count, 164,000/mm . The urea was 92
mg/dl; serum creatinine, 2,5 mg/cu; sodium, 143 mmol/liter; potassium, 8.5
mmollliter: chloridc, 118 mmol/Iiter; arterial blood pH, 7.24; and bicar-
bonate 14.6 mmol/liter. The urine was normal. a was an ultrasound
e.aminatIon of the abdomen. An clectrocardiograni revealed widening of
the QRS complex with peaked T-waves.
Thc patient's itlncss was attributed to thc combined treatment with
nonsteroidal antiinflammatoiy drugs, angiotensin-Il converting-enzyme
inhibitors, and amiloridc, with the subsequent hyperkalemia. She was
treated with intravenous calcium, glucose, bicarbonate, and cation-ex-
changt resins. All drugs were stopped. 11cr hlord pressure was controUed
with calcium antagonists, and the articular pain was treated with acet-
aminophen. The serum potassium level decrcased quickly and the glomer-
ular filtration rate improvcd. She was dischargcd with a scrum creatinine
of 2 mg/dl and a potassium of 5.8 mmol/liter. One month later, the serum
creatinine was 1.5 mg/dl and potassium 4.3 mmot/Iitcr.
DISCUSSiON
DR. DIEGO RODR1GUEZ-PUYOL (Chief Nephro1o Section,
University Hospital "PrIncipe de Asturias, "Alcalá de Henares,
and Assistant Professor of Medicine, University of Alcald,
Madrid, Spain): These patients iliustrate some of the clin-
ical problems that challenge nephrologists attending elderly
individuals (defined for the purpose of this Forum as older
than 70 years). In the first case, an eldcriy woman with a hip
fracture developed severe, acute renal failure that necessi-
tated temporary hemodialysis. She had been well previously
and had no evidence of renal disease; the pharmacologic
treatment, including dosage, was apparentiy appropriate;
and no major volume depletion was evident. In this setting,
the combination of different noxious stimuli, including
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NEPHROLOGY FORUM
CASE PRESENTATION
Patient 1. An 87-year-old woman was admitted to th  emergency r om
of the AIcaIá de Henares Hospit l after  fall at home. She had a
long-standing history of hypertension, which was well controlled with
nifed pine and ind pamide. A hyst rectomy had been pe formed 30 years
ago. Evaluation a  th  emergency r om revealed a femoral neck fracture,
and she was prepared for an internal fixation under epidur l ancsthesia.
Pre-operatoiy evaluation disclosed no sign ficant metabolic alterations,
the plasma creat ine concentration was 1.0 mgidl with a normal urinal-
y is, and no significant cardi togic problems w re d tected. surgical
procedure t ok place without complications, and the patient was treated
with intravenous fluids, nalgesics, gentam cin, and cefazolin a  standard
doses. Six days after the surgical procedure, a progre sive decrease in the
urine volume was d tected, and a nephrology consultant was contacted.
A careful analysis of th  evolution of the patient's course was unable to
detect significant hemodynamic changes after the surgical procedure, and
moderate fever was d tected only on days 2 and 3. On physical examina-
tion, she a peared well, without dyspnea, edema, or clinical signs of
volume depletion. A grade 1(V1 systolic ejection m m was audible; no
pericardial fr ction rub was heard. The surgical are  a peared well,
without infection. Neur logic examination was negative; flapping was not
d tected. The rest of the physical examination was unremarkable.
The hematocrit was 28%; he oglobin, 9.2 g/dl; white blood cell count,
10,900/ m3. The urea was 143 mg/dl; creat ine, 63 rng/dl; sodium, 130
mol/liter potassium, 4.3 mol/liter; chloride, 107 rnol/liter; calcium,
8.7 ing/dI; phosphorus, 5.4 mg dl; albumin, 2.3 g/dl; glucose, lt)7 mgfdl;
arterial blood pH, 7.33; and bicarbonate. 19.2 mol/liter. The urine was
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2+ for protein and contained 5 red cells and some granular ca ts/high-
power field. Fractional excretion of sodium was 2.7%. No eosinophils w re
d tected in the urine. An ultrasound examination of the abdomen failed to
reveal obstruction of the urinary tract.
Acute t bular necro is was diagnosed and probably was due to the use
of aminoglycosides. She required six hemodialy is sessions. Urine flow
progressively increased and she was discharged with a serum creat ine of
2.9 mg/dl. Subsequently the serum crcatinine fe l to 1.2 mgldl, with a
creati ine cle rance of 41 mI/ m.
Patient 2. An 80-year-old woman was admitted to th  emergency r om
of the Alcalá de Henares Hospital because of astheni  and muscle
weakness. She had had hypertension for a long time, but her blood
pre sure as l c t lle  ith hydruchl rothiazide, amiloride, and
capropril. The patient had no signs of renal disease, and in a recent
examination, the serum creat ine was 1.3 mgldl; urea, 68 mg dl; sodium,
137 mollliter; and potassium, 5.0 mo /Iiter. with a normal urinalysis.
Because of generalized articular pain, a general practitioner prescribed
tenoxicam, a nonsteroidal antiinfla matory agent. 10 days before admis-
sion.
Evaluation at th  emergency room showed a mi dly ob se woman who
a peared ill, with significant muscle weakness and minimal dryness of the
mouth. The hematocrit was 30.9%; hemoglobin, l0.2fdl; white bl od cell
count, 59 0/ m3; and platelet count, 164, 0/mm . The urea was 92
mg dl; serum creat ine, 2.5 mg/dI; sodium, 143 mol/liter; potassium, 8.5
mollliter: chloride. 118 mol/liter; arterial bl od pH, 7.24; and bicar-
bonate 14.6 mo /liter. The urine was normal, as w s an ultrasound
examination of the abdomen. An lectrocardiogram revealed widening of
the QRS complex with peaked T-waves.
The patient's illness was attributed to the combined treatment with
nonsteroidal antiinflarnmatory drugs, angiotensin-Il conve ing-enzyme
inh bitors, and amitoride, wit  the subsequent hyperkalemia. She was
treated with intravenous calcium, glucose, bicarbonate, and cation-ex-
change resins. All drugs w re stopped. 11cr blood pressure was controlled
with calcium antagoni ts, and the articular pain was treated with acet-
aminophen. ihe serum pota siulu level decreased quickly and the glomer-
ular filtration rate improved. She was discharged with a serum creatinine
of 2 mg dl and a potassium of 5.8 mo /litcr. One month later, the serum
creat ine was Ii gldl and pota sium 4.3 mmol/litcr.
DISCU SiON
DR. DtEGO RODR1GUEZ-PUYO!. (Chi f Nephr lo Section,
University Hospital "PrIncipe de A.sturias, "A/ca/a de Henares,
and As i.ttant Profe sor of Med cine, University of Alcald,
Madrid, Spain): These patients llustrate some of the clin-
ical problems that challenge nephro[ogi ts attending elderly
individuals (defined for the purpose of this Forum as older
than 70 years). In the first case, an elderly woman with a hip
fracture developed severe, acute renal failure that nece si-
tated temporary hemodialy is. She had b en we l previously
and had no evidence of renal disease; the pharmacologic
treatment, including dosage, was apparently appropriate;
and no major volume depletion was evident. In thi  setting,
the combination of different noxiou  stimuli, including
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minimal degrees of renal hypoperfusion and aminoglyco-
side exposure induced parenchymal damage thit practically
abolished the glomerular filtration rate. The second pa-
tient, a stable hypertensive woman receiving pharmacologic
treatment, entered the emergency room with severe hyper-
kalemia after receiving nonsteroidal antiinflammatory
drugs because of articular pain. Her plasma creatinine 'evel
had been in the normal range, and she had tolerated well
therapy with hydrochlorothiazide, amiloride, and captopril.
She had a normal blood pressure and no electrolyte
disturbances. By blocking prostaglandin synthesis, the non-
steroidal antiinflanimatory drug blunted the critical equi-
libnum in the rcnin-angiotensin-aldosterone system of the
patient, producing the dangerous hyperkalemia.
In aged individuals, this special sensitivity of the kidney
to a variety of adverse situations is reminiscent of the
biologic responses of patients with chronic renal failure.
Although the changes in renal structure and function that
develop with aging usually are considered "physiologic,"
clinicians must be aware that the renal parenchyma of the
elderly shares some of the characteristics of the chronically
damaged kidney, making necessary a careful analysis and
management of clinical situations as well as judicious
administration of drugs. In this Forum, I will describe in
detail the aging-related morphologic and functional renal
changes to provide a better understanding of the basal
renal situation of elderly individuals. In addition, I will
analyze the possible mechanisms involved in the develop-
ment of the renal parenchymal alterations in these individ-
uals. Before starting this analysis, however, let me review
briefly the available information about the biology of the
aging process in general.
General mechanisms of aging
A careful analysis of the multiple theories proposed to
explain the aging phenomenon is beyond the scope of this
discussion. However, some understanding of the general
mechanisms of aging can help us better understand the
relationship between aging and renal dysfunction.
Theories on aging have evolved according to the devel-
opment of our understanding of biology. General theories
that considered aging a global system-wide process have
been replaced by the idea that the aging of a particular
organism results from the sum of the aging of its individual
cells. This approach to the understanding of aging is
supported by much experimental evidence. Thus, in human
beings, the aging-related dysfunction of organs and tissues,
such as the brain or subcutaneous fat, is closely related to
a reduction in the number of cells. Moreover, the replica-
tive capacity of cells explanted from a variety of mammals
is roughly proportional to the life span of the animals El];
this finding suggests a relationship between cellular aging
and whole-animal aging. In addition, the WRN gene, a
gene involved in the development of Werners syndrome, a
disease characterized by the appearance of a precocious
aging phenotype in humans, is homologous to a family of
DNA helicases of Escherichia coli [2). Aging thus mighi be
a cellular autonomous process. But we must remember
that, in addition to containing individual cells, organisms
also exhibit a complex system of cell-to-cell re'ationships,
and derangements in these relationships also could be
involved in aging.
Independently of these considerations, two main theories
have been proposed to explain aging. The first hypothesis.
an environmental one, suggests that aging is the conse-
quence of the repetitive action of exogenous factors in a
normal organism, resulting in an accumulated damage that
outstrips the normal repair processes. The second, or
genetic, theory proposes that aging occurs because of a
genetic program that determines the progressive appear-
ance of the different aging-related phenotypic changes.
These two ideas arc not mutually exclusivc, and the accu-
mtiiated damage could reflect an environment-dependent
repetitive injury that triggers a genetic program of aging 12. 3].
Organisms must obtain nutrients and, in the case of
aerobic organisms, oxygen from the external media or
environment, to maintain cellular function and homeosta
sis. During the cellular metabolism of nutrients and oxygen,
different toxic intermediate molecules arise, but cells have
defense systems able to clear these molecules. Sometimes,
however, production of toxic molecules overrides the pro-
tective mechanisms; the resultant damage characterizes
progressive aging. The most important evidence supporting
this hypothesis is that dietary restriction—that is, caloric
restriction without compromising essential nutrients—is
the most reproducible way of slowing aging [4J.
Two main groups of toxic molecules likely are involved in
the aging process. Reactive oxygen intermediates (ROl)
probably have been the most widely studied. These mole-
cules, including superoxide anion, hydrogen peroxide, and
hydroxyl radicaL, among others, are formed during the
progressive reduction of molecular oxygen to form water
within the cell, but also as a consequence of the action of
different cellular enzymes [51 Reactive oxygen intermedi-
ates can induce chemical changes in many substances
essential for normal cell function, including nucleic acids.
proteins, and lipids, with subsequent structural and func-
tional cell damage. Moreover, the levels of macromolecules
exhibiting oxidative damage increase in certain tissues of
aged organisms [61. Two recent studies clearly support the
role of ROl in aging. First, drosophila strains bearing extra
copies of genes encoding both superoxide dismutase and
catalase, the main enzymes involved in ROI removal, have
longer life spans than do drosophila without the extra genes
[7). Second, the age-i mutant of C. elegaris, characterized
by an increased life span, also displays higher levels of
superoxide dismutase [81.
Advanced glycosylation end products (AGEs) comprise
the other group of molecules (formed as a consequence of
the basic living process) that seems to play a pathogenetic
t i - l st r e syste  of the
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minimal degrees of renal hy operfusio  and aminoglyco-
side exposure induced parenchymal d mage hat practically
abolished the glomerular filtration rate. Th  second pa-
tient,  stable hypertensive woman receiving pharmacologic
treatment, ntered the m rgency room with severe hyper-
kalemia after receivi g onsteroidal antiinflammatory
drugs because of articular pain. Her plasma creatinine level
had bee  in the norm l range, and s e had tolerated well
therapy with hydrochloroth azide, amiloride, and ca topril.
S e h d a norma  blood pressure and no electrolyte
disturbances. By blocking prost gla din synthesis, the non-
steroidal a tiinflammatory drug blunted the critical equi-
librium in the rcni -angiotensin-aldosterone system of the
patient, producing the dangerous hyperkalemia.
In aged ndividuals, this special ensitivity of the kidney
to  variety of adv r e si uations is reminiscent of the
biologic responses of patients wit  chronic ren l failure.
Although the changes in renal str cture and function hat
develop with a ing usually are considered "physiologic,"
clinicians must be ware hat the renal parenchyma of the
lderly shares some of the characteristics of the chronically
d maged kidney, maki g necessary  careful nalysis and
manag ment of clinical si uation as well as judicious
administrati n of drugs. In this Forum, I will describe in
detail the a ing-related morphologic and functional renal
changes to provide a b tter understa ding of the basal
renal si uati n of lderly individuals. In addition, I will
analyze the possible mechani ms in olved in th  develop-
ment of the renal parenchymal alterations in these ndivid-
uals. Before starting this analysis, however, let me r view
briefly the avai able information about the biology of the
a ing process in general.
General mechani ms of a ing
A careful analysis of the multiple theories roposed to
explain the a ing phenome on is beyond the scope of this
di cussion. However, some understa ding of th  general
mechani ms of a ing can help us better understand the
relationship between a ing and renal dysfunction.
Theories on a ing have e olved according to th  devel-
opment f o r understa ding of biology. General theories
hat considered a ing a global system-wide process have
been replaced by the idea hat the a ing of  particular
organism results from the sum of the a ing of ts ndividual
cells, This approach o the understanding of aging is
supported by much experimental evid nce. Thus, in human
beings, the a ing-related dysfuncti n of organs and tis ues,
such as the brain or subcutaneous fat, is closely related to
a reduction in the number of cells. M reover, the replica-
tive capacity of cells explanted from  variety of ammals
is roughly rop rtional to the life span of the animals El];
th s f ding suggests a relationship between cellular a ing
and whole-animal a ing. In addition, the WRN gene, a
gene in olved in th  development of W ner's syndrome, a
di ase characterized by the appearance of a prec cious
a ing phenotype in human , is h mologous to a family of
DNA helicases of Escher chia coli [2). A ing thus m ght be
a ce lul r aut n mous process. But we must r ember
hat, in addition t  containing ndividual cells, organi ms
also exhibit a complex system of cell to-cell relationships,
and derang ments in thes  relationships als  could be
in olved in a ing.
Independently of these considerations, two main theories
hav  been roposed to explain a ing. The first hypothesis.
a  environmental one, suggests hat a ing is the conse-
quence of the repetitive acti n of exogenous factors in a
normal organism, resulting i n acc mulated d mage hat
outstrips the normal repai  proc ses. Th  second, or
genetic, theory pr poses hat a ing occurs because of a
genetic program hat determines the progressive appear-
ance of the different a ing-related phenotypic changes.
These two ide s arc not mutually exclusive, and the accu-
mulated d mage could r flect a  environment-dependent
repetitive injury that triggers a genetic program of aging 12.3].
Organisms must obtain nutrients and, in the case of
aerobic organi ms, oxygen from the external media or
environment, to maintain ce lular function and homeosta-
sis. During th  cellular metabolism of nutrients and oxygen,
different toxic intermediate molecules arise, hut cells have
def nse systems able to clear these molecules. Sometimes,
however, producti n f toxic molecules overrides the pro-
ective mechani ms; th  resul ant d mage characterizes
p ogressive a ing. The most impor ant evid nce supporting
this hypothesis is hat dieta y restriction— hat is, caloric
restriction without compromising ssential nutrients—is
the most eproducible way of slowin  a ing [4].
Two main groups f toxic molecules likely are in olved in
the a ing process. Reactive oxyge  intermediates (ROl)
probably hav  been the most widely stu ied. These mole-
cules, including superoxide a ion, hydrogen peroxide, and
hydroxyl radical, among others, are formed during the
progressiv  reducti n of molecular oxygen t  form water
within th  cell, but also s a consequence of the action of
different cellular enzymes [51 Reactive oxygen intermedi-
ates ca  indu e chemical changes in many substances
ssential for normal cell functio , includi g nuclei  acids.
proteins, and lipids, with subsequent str ctural and func-
tional cell d mage. M reover, the levels of macr molecules
exhibiting oxidative d mage incr ase in certain tissues of
aged organi ms [6]. Two recent studies clearly support the
role of ROI in a ing. First, drosophila strains bearing extra
copies of gen s encoding both superoxi e dismutase and
catalase, the mai  enzymes in olved in ROl removal, have
longer life spans than o drosophila without the extra genes
[71• Second, the age-i mutant of C. elegaris, characterized
by a  incr ased life span, also displays igher levels of
superoxi e dismutase [8].
Advanced glycosylation end products (AGEs) comprise
the other group of molecules (formed s a consequence of
the bas c living process) hat seems to pl y  pathogenetic
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Fig. 1. Schematic representation of the aging
process, considering the organism as the sum
of Its different cells. Abbreviations are: Rot,
reactive oxygen intermediates; AGE, advanced
glycosylation end products; ruedialors, other
possible mediators.
role in aging development [9]. Formed by the long-term
interaction of reducing sugars, such as giucose or fructose,
with the amino groups of intracellular or extracellular
proteins [9], AGEs are increased in several pathologic
situations, particularly diabetes, and in aged organisms.
Protein glycosylation or the interaction of AGEs with
specific cell receptors is associated with the development of
functional and structural changes similar to those charac-
terizing aging [9]. A close relationship exists between AGE
and RO!, as it seems that ROl are generated in cells after
the interaction of AGEs with their receptors 10J. More-
over, glycated proteins can undergo oxidative damage, with
the subsequent accumulation of glycoxidation products
such as N-epsilon (carboxymethyl) lysine, which are con
sidered good markers of aging-related tissue damage [1 1].
The genetic theory of aging proposes that the life span of
a particular organism is determined by a specific genetic
program, which culls older individuals from the general
population. One interesting piece of evidence supporting
this theory is the observation that Pacific salmon undergo
rapid senescence after spawning [2]. Moreover, a limited
number of genes, including age-i, daf-2, and clk in C.
elegans and WRN in human beings, have been related to
the development of aging-related phenotypic changes [2,81.
The exact mechanism of this programmed cell death has
not been adequately defined; several possibilities have been
proposed [2,3]. The "telomere shortening theory" proposes
that cells do not completely rep'icate their chromosomes
during a cell division cycle, so that very late replicating
DNA sequences are lost. If certain nonessentiat repetitive
DNA sequences were at the ends of replicative units,
essential genes would not be lost until a number of divisions
were achieved. The theory of "terminal differentiation"
posits programmed cell senescence as the consequence of
the activation or inactivation of particular genes after a
certain number of cell divisions. Other hypotheses envision
aging as the result of minimal but repetitive DNA injuries,
or progressive loss of copies of important genes. Neverthe-
less, these theories only partially explain the aging phenom-
enon, particularly at a cellular level, and a universal mech-
anism of cell aging has not yet been determined.
Figure 1 summarizes the aging process. Living organisms
are provided with a genetic program, including perhaps a
specific aging program, which controls their different func-
tions. To maintain these functions, organisms must obtain
nutrients and oxygen from the external medium and, in the
processing of these metabolites, toxic molecules are
formed. Although organisms can disarm most of these
molecules, a small number of them can interfere with
normal basic functions, or even with the genetic program,
thus determining a particular rate of aging. Other external
stimuli also might influence the aging process.
Aging-related renal changes
Morphologic changes. Although asscssment of specific
aging-related morphologic renal changes in the elderly is
not easy because of the high prevalence of superimposed
vascular or inflammatory diseases, studies in apparently
disease-free individuals have provided valuable informa-
tion (Table 1) [12, 13J. Renal mass increases progressively
from about 50 g at birth to over 400g at the fourth decade,
and then declines to under 300 g by the ninth decade. The
loss of renal mass mainly depends on progressive atrophy of
renal cortex, with relative sparing of the medulla. The
cortical atrophy roughly reflects a decreased number of
functioning nephrons. Under age 40, few glomeruli appear
sclerosed; in contrast, by the eighth decade, between 1O
and 30% of the glomeruli are completely sclerosed, the
Organism ]
t
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Fig. 1. Schematic representation of the aging
proce s, considering the organism as the sum
of Its di ferent ce ls. A breviations are: Rot,
reactive oxygen intermediates; AGE, advanced
glycosylation end products; mediators, other
po sible mediators.
role in aging development [9]. Formed by the long-term
interaction of reducing sugars, such as glucose or fructose,
with the amino groups of intrace lular or extrace lular
proteins [9], AGEs are increased in several pathologic
situations, particularly diabetes, and in aged organisms.
Protein glycosylation or the interaction of AGEs with
specific ce l receptors is a sociated with the development of
functional and structural changes similar to those charac-
terizing aging [9]. A close relationship exists between AGE
and RO!, as it seems that ROl are generated in ce ls after
the i tera ti  f  [10]. More-
over, glycated proteins can undergo oxidative damage, with
the subsequent accumulation of glycoxidation products
such as -epsil  ( r   -
sidered good markers of aging-related ti sue damage [11].
The genetic theory of aging proposes that the life span of
a particular organism is determined by a specific genetic
program, which cu ls older individuals from the general
population. One interesting piece of evidence supporting
this theory is the observation that Pacific salmon undergo
rapid senescence after spawning [2]. oreover, a limited
number of genes, including age-i, daf-2, and elk in C.
elegans and WRN in human beings, have b en related to
the development of aging-related phenotypic changes [2,81.
The exact mechanism of this programmed cell death has
not b en adequately defined; several po sibilities have b en
proposed [2,3]. The "telomere shortening theory" proposes
that ce ls do not completely replicate their chromosomes
during a ce l division cycle, so that very late replicating
DNA sequences are lost. If certain none sential repetitive
DNA sequences were at the ends of repticative units,
e sential genes would not be lost until a number of divisions
were achieved. The theory of "terminal di ferentiation"
posits programmed ce l senescence as the consequence of
the activation or inactivation of particular genes after a
certain number of ce l divisions. Other hypotheses envision
aging as the result of minimal but repetitive DNA injuries,
or progre sive lo s of copies of important genes. Neverthe-
le s, these theories only partia ly explain the aging phenom-
enon, particularly at a ce lular level, and a universal mech-
anism of ce l aging has not yet been determined.
Figure 1 summarizes the aging proce s. Living organisms
are provided with a genetic program, including perhaps a
specific aging program, which controls their di ferent func-
tions. To maintain these functions, organisms must obtain
nutrients and oxygen from the external medium and, in the
processing of these etabolites, toxic olecules are
formed. Although organisms can disarm most of these
olecules, a s a l nu ber of the  can interfere with
normal basic functions, or even with the genetic program,
thus determining a particular rate of aging. Other external
stimuli also might influence the aging proce s.
Aging-related renal changes
orphologic changes. Although a se sment of specific
aging-related morphologic renal changes in the elderly is
not easy because of the high prevalence of superimposed
vascular or inflammatory diseases, studies in apparently
disease-free individuals have provided valuable informa-
tion (Table 1) [12, 13]. Renal ass increases progressively
fro  about 50 g at birth to over 400 g at the fourth decade,
and then declines to under 300 g by the ninth decade. The
loss of renal ass mainly depends on progre sive atrophy of
renal cortex, with relative sparing of the edu la. The
cortical atrophy roughly reflects a decreased number of
functioning nephrons. Under age 40, few glomeruli appear
sclerosed; in contrast, by the eighth decade, between l0'
and 30  of the glomeruli are completely sclerosed, the
rgar  ]
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Table 1. Morphologic changes in the kidneys of cidcrv individuals
glomeruli of the outer cortex being especially affected. The
remaining functioning glorneruli appear to increase in size.
although recent measurements performed by computer-
assisted image analysis suggest that after the fourth decade
glomerular size declines slightly [14]. The glomerular
changes that determine the development of sclerosis have
been studied previously [12, 13]. Mesangial matrix in-
creases progressively, and glomerular basement membrane
undergoes progressive thickening; free intraglomerular
anastomoses appear and functioning capillary loops are
reduced (so-called "glornerular simplification"). Eventu -
ally, the increased extracellular matrix condenses into
hyaline material and collapses the glornerular tuft, finally
inducing complete glomerular sclerosis. Degeneration of
glomeruli in the renal cortex in turn results in atrophy of
the afferent and efferent arterioles; in the juxtamedullary
area, glomerulosclerosis seems to cause the formation of a
direct channel between these two arterioles. These chan-
nels could contribute to the maintenance of medullary
blood flow as cortical perfusion declines. Tubular struc-
tures also decrease with aging. Although some studies
suggested a dissociation between glomerular and tubular
atrophy, this hypothesis has not been confirmed, and a
close relationship appears to exist between degenerative
changes in glomeruli and those in tubules [12, 13]. Inter-
stitial changes, with increased fibrosis, also frequently occur
in the aging kidney (12, 13].
Studies of aging-related renal changes in experimental
models, performed mostly in albino rats, are consistent with
the pathologic findings in humans [15]. Two strains of rats,
Fisher 344 and Sprague-Dawley, are especially prone to the
development of age-related nephropathy, but other albino
strains also develop variable degrees of renal damage with
aging [15). In these animals, glomerular sclerosis is readily
demonstrated after 24 months, but increased glomerular
basement membrane thickness and progressive expansion
of mesangial matrix arc detected as early as 3 months (15}.
Giomerular size of the intact glomeruli increases with age
[14, 16]. It is interesting that Hayashida et al noted an
increase in the number of mesangial cells with age
Intratubular casts occur more frequently in old rats, with
flattening and atrophy of the tubular epithelia. Interstitial
fibrosis, a constant characteristic of these animals [15], has
been detected as early as after 8 months in Lewis rats [18].
In fact, some authors believe that the interstitial changes
precede gloinerular sclerosis in the renal aging process [191.
Recently, our group has performed morphologic studies
in 24-month-old Wistar rats. The morphologic changes
observed were similar to those previousiy described (Fig.
2). After staining with Syrius red, we used a computer-
assisted planimetric procedure deve'oped at the Pathology
Department of the University of Granada, which allowed
us to accurately measure mesangial matrix expansion and
interstitial fibrosis. Mean increases of 273% and 181% were
detected, respectively, for these two parameters, when
compared to 3-month-old animals [20].
To complete the analysis of aging-related morphologic
changes, let me comment on the biochemical nature of the
extracellular matrix accumulation in the aging kidney.
Studies performed both in human beings and in rats have
confirmed that the chemical composition of the glomerular
basement membrane differs between young and old indi-
viduals. Several changes have been detected in the latter,
including increased non-enzymatic glycosylation of proteins
and changes in the degree of sulfation of glycosaminogly-
cans, but the most widely found biochemical change is
increased collagen content [14]. However, Abrass et al
recently questioned the hypothesis of collagen accumula-
tion by performing immunofluorescence studies in Fisher
344 rats with a wide panel of antibodies [19]. These authors
demonstrated a moderate increase of collagens I and Ill
only in areas with interstitial fibrosis, but detected no
changes in collagens 1, III, and IV at the glomerular level.
The changes observed in the glomerular tuft, particularly in
the glomerular basement membrane, were related to an
increased content of various laminin isoforms, whereas in
the interstitial compartment, they observed a generalized
immunostaining for fibronectin and thrombospondin. The
relationship between interstitial fibrosis and collagen I
accumulation also seems to be supported by the demon-
stration of increased levels of type-I collagen mRNA in the
cortex of old rats [21]. In contrast to the results from
Abrass, preliminary results from our laboratory demon-
strate an increased collagen type-IV mRNA (alpha-i
chain) in the renal cortex of 24-month-old Wistar rats (Fig.
3). This finding suggests that accumulation of this collagen
plays a role in the genesis of the morphologic renal changes
observed in aged rats. Differences in rat strain, age of the
rat at the time of the study, or sensitivity of the techniques
might account for the apparent discrepancies detected in
the different studies.
Functional changes. Elderly kidneys manifest significant
functional as well as morphologic, changes (Table 2). In
human beings, rena' blood flow (RBF) decreases about
10% per decade after the maximum reached in young
Macroscopic changes
Vascular changes
Ghrneru1ar changes
Tubular changes
Interstitial changcs
Reduced size and weight
Relative cortical alrophv
1-Jyalinosis of arterial walls
Increased number of scierosed glomeruJi
Hypertrephy of the remnant glomerui?
Increased thickness ol basal membrane
MeangiaJ nlalrix expansion
1rrtguIar fusion of fooi processes
Reduction in the number of tubuks
Atrophy of the tubular epithelium
Tubular di'ation
Increased thickness of basal mcmhranc
Iiiterstitiaj fibrosis
Well documented in rats, but controversy exists in humans.
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Table 1. M rphologic changes in the kidneys of ldcrtv in ividuals
glomeruli of the outer cortex being especially aff cted. The
remaining funct oning glomeruli appear to incr ase in size.
although recent measur ments pe formed by computer-
assisted image analy is suggest ha  af er the fourth decade
glomerular size declines slightly [.14]. The glomerular
changes that determine th  development of sclerosis have
been stu ied previously [12, 13]. Mesangial matr x in-
cr ases progressively, and glomerular bas ment embrane
undergoes progressive thickening; free intraglomerular
nastomoses appe r and functioning capillary loops are
reduced (so-called "glomerular simplification"). Eventu-
ally, the increased extrace lular matrix condenses into
hyaline material and collapses the glonierular tuft, finally
inducing complete glomerular sclerosis. Degenerati n of
glomeruli in th  renal cortex in tu n results in atrophy of
the afferent and fferent a terioles; in the juxtamedullary
rea, glomeruloscierosis seems to cause the formati n of a
dire t channel between these two a terioles. These chan-
nels could contribu e o the mainte ance of medullary
blood flow as cortical perfusion declines. T bular struc-
tures also decrease with aging. Although some studies
sugg sted a dissociation between glomerul r and t bular
atrophy, this hypothesis has not been confirmed, and a
clos  relationshi  appears to exist between d g nerative
changes in glomeruli and those in t bules [12, 13]. Inter-
stitial changes, with incr ased fibrosis, also frequently occur
in the a ing kidney (12, 13].
Studies of aging-related renal changes in experimental
models, pe formed mostly in albino rats, are consis ent with
the pathologic fi dings in humans [15]. Two strains of rats,
Fisher 344 and Sprague-Dawley, are especially prone to the
d velopment of ag -related nephropathy, bu  other albino
strains also develop v riabl  d grees of renal d mage with
a ing [15). In these animals, glomerular sclerosis is readily
demons rated after 24 months, but incr ased glomerular
bas ment embrane thickness and progressive expansion
of mesangial matrix arc de cted as early as 3 months (15].
Giomerular size of the in act glomeruli incr ases with age
[14, 16]. It is interesting that H yashida et al noted an
increase in the number of mesangial cells with age [17].
Intratubular casts occur more frequently in oki rats, with
flattening and atrophy of the t bular epithelia. Interstitial
fibrosis, a cons ant characteristic of these animals [15], has
been de cted as early s after 8 months in Lewis rats [18].
In fact, some authors b li ve that the interstitial changes
precede glo nerular sclerosis in the renal a ing process [19].
Recently, ou  group has pe formed morphologic studies
in 24-month-old Wistar rats. The morphologic changes
observed were s milar o those previously described (Fig.
2). After staining with Syrius red, we used a computer-
a sisted planimetric procedure d veloped at the Pathology
Department of the University of Granada, w ich allowed
us to accurately measure mesangial matrix expansion and
interstitial fibrosis. Mea  incr ases of 273% and 81% were
det cted, respectively, for these two parameters, when
compared to 3-month-old animals [20].
T  complete the analysis of aging-related morphologic
changes, let me comment on the biochemical nature of the
extrace lular matrix acc mulatio  in the a ing kidney.
Studies pe formed both in human beings and in rats have
confirmed hat the chemical compositi n of the glomerular
basement embrane differs between young and old ndi-
viduals. Several changes hav  been de cted in the latter,
including incr ased o -enzymatic glycosylati n of proteins
and changes in th  degree of sulfati n of glycosa iinogly-
cans, but the most widely found biochemical change is
increased collagen content [14]. How ver, Abrass et al
recently questioned t e hypothesis of collagen accumula-
tion by pe forming immunofluorescence studies in Fisher
344 rats with a wide panel of antibodies [19]. These authors
demons rated a moderate increase of collagens I and III
only in areas with interstitial fibrosis, but det cted no
changes in collagens I, III, and IV at the glomerular l vel.
The changes obs rved in the glomerular uft, particu arly in
the glomerular basement embrane, we  related to an
increased co tent of various lamin n isoforms, whereas in
the interstitial compartment, they observed a g neralized
immunostaining for fibronecti  and thrombospondin. The
relationship betwee  interstitial fibrosis and collagen I
accumulation al o seems to be supported by th  demon-
s rati n of incr ased levels of type-I collagen mRNA in the
cortex f old rats [21]. In contrast o th  results from
Abrass, prel mina y results from our laboratory demon-
strate a  increased collagen type-IV mRNA (alpha-i
chain) in th  renal cortex of 24-month-old Wist r rats (Fig.
3). This fi ding suggests hat acc mulati n of this collagen
plays a role in th  genesis of the morphologic renal changes
observed in aged rats. Differences in rat strain, age of the
rat at the time of the study, or sensitivity of the techniques
might account for the apparent discrepancies de cted in
the different studies.
Functional changes. Elderly kidneys manifest significant
function l as well as morphologi , changes ('Table 2). In
human beings, renal blood flow (RBF) d cr ases about
10% per decade after the maxi um reached in young
Ma ros opic changes
Vascular changes
Glonierular changes
Tubular changes
In erstitial changes
Reduced size and weight
Relative cortical atrophy
1-Jyalin sis of arterial walls
Increased number of sci rosed glomeruli
Hvp rtrophy of the remnant glomeruli
Incr ased thickness of basal embrane
Mes ngi l matrix expansion
Irregular fusi n f foot proc sses
Reduction in the number of t bules
Atrophy of he tubular epithelium
Tubular dilation
Incr ased thickness of basal embrane
In erstitial fibrosis
Well documented in rats, but controversy exists in humans.
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Fig. 2. Morphologic changes in the renal
cortex of 24-month-old Wistar rats. (1) Diffuse
gtomerular and tubular changes, with cystic
appearance and atrophy of the glomerular tuft
of some glomeruli, gIomeruIoscIeross, tubular
dilation, and intratubuar casts (PAS X 100).
(2) Tubular atrophy, teduplication of basal
membranes, and interstitial expansion (PAS X
400). (3) Magnification of a scleroscd
glornerulus. near another gtomerulus with cyst(c
appearance. in an area with interstitial
ecpansion (PAS X 400). (4) Arterolar
hyalinosis (PAS x 600).
1 2 3 4
adulthood. Thus, renal plasma flow (RPF) of approxi-
mately 600 ml/min/I.73 m2 during the third decade de-
creases to about 300 rnl/minJl.73 m2, a 50% reduction, in
the ninth decade 112, 13]. The decrease in RBF is associ-
ated with significant increases in afferent and efferent
arteriolar resistances [12, 13J. The decline in RBF cannot
he exp'ained as a secondary phenomenon associated with
the previously described renal mass reduction, as specific
studies designed to answer this question demonstrated that
the decreased RBF was accompanied by a real decline in
blood perfusion per unit of renal tissue mass (22]. Neither
can changes in cardiac function account for the reduction in
this parameter, as the minimal reduction in the percentage
of cardiac output directed to the kidney (that occurs in the
elderly) does not explain the observed decline in RBF [23].
Studies utilizing the xenon washout technique have dem-
onstrated that the reduction in RBF is not uniform
throughout the kidney. In fact, and according to the
anatomic descriptions, cortical blood flow is preferentially
decreased in the elderly, with a relative sparing of the blood
flow in juxtamedullary glorneruli [22]. As these glomerular
structures have a higher filtration fraction than do the
cortical glorneruli, the observation that filtration fraction
increases with advancing age could be ecplained by this
observation.
Table 2. Functional changes in the kidneys of elderly ndividuaIs
COL (V
1 2 3 4
28S
Fig. 3. Expression of the collagen type4VmRNA (a-i chain in the renal
cortex ri-om J-month.old (lanes 1 and 2) and 24-month-old (lanes 3 and 4)
rats.
Renal blood flow Decreased
Relative increasc of medullary blood flow
Glomerutus Decreased glomerufar filtration rat&
Increased filtration fraction
Increased permeability to macromoleculesb
Tubule Impaired ability (or sodium handling
Deranged tubular transport
Impaired concentration and dilution
Impaired acidification
Other Decreased synthesis ol renin
Decreased 1-aipha-hydroxylase activity
GeneraUy accepted in humans but not in rats.
b Increased prevalence of mcroaIbuminuria in humans. Over protein-
uria in rats.
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Changes in RBF in experimental anirnas differ from
those obsei'ed in human beings: the absolute values of
RBF remain stable between 3 and 20 to 24 months [16, 24,
25j, and even slight increases in this parameter have been
observed in 15- to 18-month-old Sprague-Dawley rats [24,
26]. When RBF was factored by kidney weight, however, it
significanttv decreased with aging [16, 24J; these data have
been sometimes interpreted as indicative of an aging-
related significant derangement of RBF. The analysis of
preglomerular and postglonierular resistances by mi-
cropuncture has vicided different results, depending on the
rat strain. Thus, these resistances were increased in old
Munich-Wistai rats 1161, but were decreased in Sprague-
Dawley animals (25 27}.
Glorneruar filtration rate (GFR) has been studied ex-
tensively in the elderly. Cross-sectional studies have dem-
onstrated that GFR decreases progressively after age 30 to
40 years [12. 13]. This decreased GFR was not only
detected in cross-sectional studies but also in longitudinal
studies. The Bajtiniore Longitudinal Study of Aging a'so
found a progressive decline of glomerular filtration with
aging. The rate of decline was 0.8 ml/minll.73 m2/year, a
rate similar to that previously reported in cross-sectional
studies [281. Interestingly, GFR did not change in approx-
imately one-third of the patients included in this longitudi-
nal study [28].
In contrast to the decline in GFR, plasma creatinine does
not change with increasing age. As it happens, muscle mass,
from which creatiiiiiie is derived, decreases with age at
approximately the same rate as does GFR. In consequence,
the age-related loss of GFR is not reflected by an increased
concentration of plasma creatinine. Thus, this parameter
must be used with caution iii aged populations to assess
GFR, as it underestimates renal function; the commonly
used formulas for estimating creatinine clearance from
plasma creatinine values always take into account the age
of the patients.
Another aspect of glomerular function that has been
extensively studied is the permselectivity of the filtration
barrier. Although some reports describe an increased prev-
alence of proteinuria in a population of persons over 65
years [29J, only a minority of disease-free patients over 80
years show clinical proteinuria [13]. Moreover, when the
glomerular permeability to macromolecules has been stud-
ied, no differences were detected between young and old
individuals [30]. Thus, it seems that the permselectivity of
the glomerular filtration barrier in human beings is only
minimally altered in the elderly.
Again, glomerular function in old rats differs from that in
older humans. Assessing different reports on GFR is
difficult because data arc frequently expressed corrected
for the body and kidney weight, and these two variables
increase in old anima's. but it does seem that GFR remains
stable in albino rats until 18 to 24 months of age f16, 24]
and then declines progressively. On the other hand, pro-
teinuria is a constant manifestation of renal dysfunction in
old rats in strains that develop glomerulosclerosis [15, 31].
Although the exact nature of this selcctivity defect has not
been elucidated, some evidence points to a combined
charge and size defect as responsible for the aging-related
increased proteinuria [32].
Tubular absorption of sodium scems to be impaired as a
consequence of aging. When old individuals are sodium-
deprived, sodium excretion progressively declines, but it
takes longer to achieve equilibrium than when younger
people undergo the same deprivation. The mean half-time
for reduction of sodium excretion is 17 hours in individuals
less that 30 years old, but is prolonged to 31 hours in
subjects more than 60 years old. Nevertheless, the elderly
can achieve a sodium equilibrium even when given diets
with a very low sodium content [33]. Old subjects also have
problems with sodium overloads, and edema and hyperten-
sion frequently occur in this population. Short-term sodi-
um-loading studies show distinct age-related sodium excre-
tion patterns: after a 2-liter normal saline load, individuais
older than 40 years show a lower 24-hour sodium excretion
(with a significantly greater portion of the sodium excreted
at night) than do their younger counterparts [34].
Perhaps one of the best-known aspects of tubular dys-
function in the elderly is their relative inability to ade-
quately concentrate and dilute the urine. Studies compar-
mg the maximal urinary density or osmolarity after water
deprivation in young and old individuals have clearly
demonstrated that kidneys from old subjects do not form
urine as concentrated as that of young people [35]. Renal
diluting ability also is impaired in elderly individuals.
During water diuresis, urine osmolarity in old subjects is
significantly higher than that in young subjects, and solute.
free water clearance is lower 133]. The same defects in
urinary concentration and dilution also have been de-
scribed in laboratory rats (t5j.
Other disorders of tubular transport widely studied are
decreases in sodium-hydrogen exchange and in sodium-
coupled phosphorus reabsorption. The latter defect also
has been demonstrated in laboratory animals and even in
preparations of brush-border vesicles [15, 36]. This age.
related decline in sodium-dependent phosphate transport
precedes the effect of age on sodium-hydrogen exchange in
brush-border membrane vesicles [37). These data suggest
that all membrane transport functions at the proximal
tubule are not similarly affected during the aging process.
As in the case of the other tubular functions, under normal
physiologic conditions older individuals maintain normal
acid-base excretion. However, the elderly do have a de-
creased time-referred acid excretion (when compared with
young controls) when challenged with an acid load; in
addition, young subjects excrete a significantly higher pro-
portion of the acid load as ammonium [38J.
The renal aging process is also characterized by de-
creased renin syffihesis. Studies in humans and in rats have
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Changes in RBF in experiment l animals differ from
those obs rved in human beings: the absolute values of
RBF remain stabl  between 3 and 20 to 24 months [16, 24,
25], and even slight incr ases in this parameter hav  been
obs rved in 15- to 18-month-old Sprague-Dawley rats [24,
26]. When RBF was factored by kidney weig t, however, it
significantly d cr ased with a ing [16, 24]; these dat  have
been sometinles interpreted as indicative of an aging-
related significant derang ment of RBF. The nalysis of
preglomerul r and postglonierular resistances by mi-
cropuncture has vie Ided different results, depending on the
rat strain. Thus. thes  resistances were increased in old
Munich-W st r rats 161, but were d cr ased in Sprague-
Dawlev animals ( 5 27].
Glome ular filtration rate (GFR) has been studied ex-
tensively in the lderly. Cro s-sectional studies hav  dem-
ons rated hat GFR d cr ases progressively after age 30 to
40 years [12. 13]. This decreased GFR was n t only
de cted in cro s-sectional studies but also in longitudinal
studies. The Baltimore Longitudinal Study of Aging also
found a progressiv  decline of glomerular fil ration with
aging. The rate of decline was 0.8 l/minll.73 m2/ycar, a
rate s milar o that previously reported in cro s-sectional
studies [281. Interestingly, GFR did not change in approx-
imately one-third of the patients included in this longitudi-
nal study [28].
In contrast to th  decline in GFR, plasma creatinine does
not change with increasin  age. As it happens, muscle mass,
from w i h creat nine is derive , d creases with age at
approximately the same rate as does GFR. In consequence,
the ag -related loss of GFR is not refl cted by an incr ased
concen rati n of plasma creatinine. Thus, this parameter
must be used with caution in aged opulations to a es
GFR, as it underestimates renal function; the commonly
used formulas for estimating creatiriine clearance from
plasma creatinine values always take into account the age
of the patients.
Another aspect of glomerular function that has been
xtensively stu ied is th  permselectivity of the fil ration
bar ier. Although som  reports describe a  incr ased prev-
alence of proteinuria in a opulation of persons over 65
years [29J, only a minority of dis ase-free patients over 80
years show clinical proteinuria [13]. Moreover, when the
glomerular permeability to macr molecules has been stud-
ied, no differences wer  de cted between young and old
individuals [30]. Thus, it seems hat th  permselectivity of
the glomerular fil ration bar ier in human beings is only
minimally altered in the lderly.
Again, glomerular functio  in old rats differs from hat in
older humans. Assessing different reports on GFR is
difficult because data are frequently expr ssed corr cted
for the body and kidney weight, and these two v riables
incr ase in old animals, hut it does seem hat GFR remains
stable in albino rats until 18 to 24 months of age f 16, 24]
and then declines progressivelY. On the other hand. pro-
teinuria is a constant manifestati n of renal dysfunctio  in
old rats in strains hat develop glomerulosclerosis [15, 31].
Althoug  the exact nature of this selectivity defect has not
been elucidated, some evidence points to a combined
charge and siz  defect as responsible for the aging-related
incr ased proteinuria [32].
T bul r absorpti n of sodium seems to be impaired s a
consequence of aging. When old individuals are sodium-
deprived, sodium excretion progressively declines, but it
takes longer to achi ve equilibrium than when younger
people undergo the sam  deprivation. The mean half-time
for reducti n of sodium excretion is 17 hours i  individuals
less that 30 years old, hut is prolonged to 31 hours in
subjects more than 60 years old. Nevertheless, the lderly
c n achi ve a sodium equil brium ven when given diets
with a very low sodium co ent [33]. Old subjects also have
problems with sodium overloads, an  edema and hyp rten-
sion frequently occur in this opulation. Short-term sodi-
um-loading studies show distinct ag -related sodium excre-
tion patterns: after a 2-liter normal saline load, individuals
older than 40 years show a lower 24-hour sodium excretion
(with a significantly gr ater p rti n of the sodium excreted
at night) than do their younger counterparts [34].
Perhaps one of th  best-known aspects of t bular dys-
functio in the elderly is their relative inabili y to ade-
quately concen rate and dilute the urine. Studies cornpar-
mg the maximal urinary density r osmolarity after water
deprivatio in young and old individuals have clearly
demons rated that kidneys from old subjects d  not form
urine as concen rated as that of young people [35]. Renal
diluting ability also is impaired in lderly ndividuals.
During water diuresis, urine osmolarity in old subjects is
significantly higher than that in young subjects, and solute-
free water clearance is lower [33]. The sam  defects in
urinary concen ration and dilution also have been de-
scribed in laborato y rats
Other disorders of t bular transport widely stu ied are
decreases in sodium-hydrogen exchange and in sodium-
coupled phosphorus reabsorption. The latter defect also
has been demons rated in laboratory animals and even in
preparations of brush-border vesicles [15, 36]. This age-
related decline in sodium-d pendent phosphate transport
precedes the ffect of age on sodium-hydrog n exchange in
brush-border embran  vesicles [37]. These data suggest
th t all embrane transport functions at the proximal
t bule are not s mi arly aff cted during the aging process.
As in the case of the other t bular functions, under normal
physiologic conditions older ndividuals maintain normal
acid-base excretion. How ver, the elderly do have a de-
cr ased tim -ref rred acid excretion (when compared with
young controls) when challenged with an acid load; in
addition, young subjects excrete a significantly ighe  pro-
porti n of the acid lo d s am ionium [38].
Th  ren l aging proces is also characterized by de-
cr ased renin synthesis. Studies in humans and in rats have
Nephmlogy !on,n: The avig kiclnc 2253
demonstrated decreased concentrations and activities of
plasma renin despite normal plasma concentration of renin
substrate, as weU as a decreased reial renin content Iii
edcrly individuals, in these subjects. maneuvers designed
to stimuatc rcnin secretion amplified the differences in
plasma renin levels with respect to the young popu'ation
[39]. Jung et at demonstrated decreased rcnin rnRNA
content in renal tissue in 12-month-old Spraguc-Dawlcy
rats, even in the absence of significant changes in ren&
renin [401. In contrast, Corman et al detected a significantly
decreased rcnin content in 30-month-old female WAG/nj
rats, without changes in renin mRNA expression [41]. A
deficit in 1-alpha-hydroxylase activity is another character-
istic of aged subjects. As a consequence of this defect,
plasma levels of I ,25-d i hydroxycholecalciferol decrease in
this population, with a subsequent derangement in calcium
homeostasis [421.
Mechanisms responsible for renal changes during aging
Analysis of the mechanisms involved in the dev&opmcnt
of aging-related renal changes has been performed at two
levels. Most studies have looked for the immediate reasons
that explain the changes detected in renal structure and
function in old human beings or animals. However, these
studies have not established a re1ationshp between the
specific mechanisms studied and the aging process. In
consequence, a second set of studies or hypotheses have
tried to estahish a casual link between the aging process
itself and the possible mechanisms involved in the genesis
of the renal changes. In this second part of this discussion,
I wilt focus on mechanisms responsib'e for aging-related
morphologic and functional renal changes, and links be-
tween the aging phenomenon and these mechanisms.
Morphologic. Aging-related morpho'ogic renal changes
are similar to those detected in renal disease and experi-
mental models characterized by progressive chronic renal
failure, includkig glomerulonephritis, diabetes, and surgical
reduction of renal mass [43J. Although the exact biochem-
ical composition of the expanded cxtracellular matrix in
aging kidneys is not fully comparable to that in any of those
pathologic situations [19], one could hypothesize that aging
shares some of the pathogenetic mechanisms proposed for
these discases. Table 3 lists the most widely accepted
mechanisms of extracellular matrix expansion and changes
in cefi numbers in the kidney in progressive renal diseases.
Some of these mechanisms have been widely explored n
experimental models of glomerulonephritis or diabetes, as
wefi as in rats with surgical renal mass reduction [43—481.
Four main aspects of the tab'e must be stressed. First, the
number of cells at a particular time in disease progression
is regulated by the balance between cell proUferation and
apoptosis (programmed cell death). Second, increased cell
numbers can precede glomerulosclerosis and interstitial
fibrosis, even in situations in which cell proliferation is not
readUy detected. Third, changes in the complex equilibrium
Table 3. Mechanisms tnd factors involved in the expansion of
extrtceUuIur matrix and changc in cel' numbers in
progressive renal diseases
General median isms
Changes in the proliferation rate of resident or infiltrating cells
Changes in the apoptosis rate of resident or infiltrating cells
increased synthesis of normal or abnormal extracellular matrix
components
Decceased degradation of norma' or ibnormal extracellular matrix
components
Factors involved in the regulation of these mechanisms
Growth factors: PDGF, EGF, TGFP, FGF, 1GF-1
Cytokiiies Il-i, fl-13, TNF
Vasoactive peptides: All, ET, ANP
Lipid mediators: POE2, P012, TxA,, PAF
Others: NO, ROt
Abbreviations: PDGF, platelet-derived growth factor; EGF, epidermal
growth factor: TGFP, transforming growth factor j3; FOF, fibroblastic
growth factor; IGF-1, insulin-like growth factor 1; 11-1, interleukin-I; 11-13,
interleukin-13; TNF. tumor necrosis factor; All, angiotensin 11; ET,
endothelin; ASP, atrial natriuretic peptide; POE-,, prostagandin E2;
pGr,, prostacyctin; TxA2, thromboxane A,; PAF, platelet-activating fac-
tor; NO, nitric oxide; ROl, reactive oxygen intermediatcs.
between matrix synthesis and degradation are, perhaps, the
main critical point in fibrosis development. Fourth, from a
functional point of view, a wide overlap exists between the
dassical growth factors and different vasoactive factors, as
the former may induce significant hemodynamic effects,
whereas the latter may modif' the rate of proliferation and
protein synthesis in different cells.
These mechanisms have been scarcely explored in aging.
The number of niesangial cells increases in the early stages
of aging in rats [171, but no additional studies have con-
firmed this finding. It would be very important to assess the
rates of proliferation and apoptosis of the different renal
cells as a function of age to ascertain thc importance of
these phenomena in the genesis of the progressive replace-
ment of cells by extracellular matrix. In addition, glomer-
ular hypertrophy frequently occurs in elderly individuals
and old rats [12—141. Although this hypertrophy has been
frequently considered the consequence of intrarenal hemo-
dynamic changes some authors believe that the hyper-
trophy dcpends on the release of local mediators, including
growth factors [50J, and that it could be an indirect marker
of the increased local production of growth-promoting
metabolites. Only one recent report has analyzcd the levek
of one of these growth factors in elderly individuals. Chou
et al demo nstratcd an inverse relationship between urinary
epidermal growth factor cxcretion and age, and suggested
that a reduced production of this growth factor retards thc
repair process at the kidney level [51. In contrast, different
vasoactive autacoids have been studied as possiblc media-
tors of the functional changes of the aging kidney, and it is
now a well-recognized fact that autacoids regu'ate cell
proliferation and/or extracellular matrix synthesis. Thus,
angiotensin IL and endothelin have well-defined effects on
cell proliferation, whereas nitric oxide (NO) and atrial
natriuretk peptide (ANP) possibly inhibit cell growth and
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demons rated decreased concen rations and activities of
plasma renin despite norma  plasma concen ration of renin
substrate, as weU as a decreased renal renin content in
elderly ndividuals, in the e subjects. maneuvers designed
to stimulate rcnin s cretion amplified the differences in
plasma renin l vels with respect to the young population
[39]. Jung e at demonstrated decreased rcni  mRNA
content in renal tissue in 12-month-old Sprague-Dawley
rats, ve in the absence of significant changes in renal
renin [401. In contrast, Corman et at det cted a significantly
decreased renin content in 30-month-old female WAG/nj
rats, without changes in renin mRNA expression [41]. A
deficit in 1-alpha-hydroxylase activity is another character-
stic of aged subjects. As a consequence of this defect,
plasma levels of 1,25-dihydroxycholecalciferol d crease in
this opulation, with a subsequent derangement in alcium
homeo tasis [42].
Mechanisms responsible for renal changes during aging
Analysis of the mechani ms involved in th  development
of aging-related renal changes has been performed at two
l vels. Most studies have looked for the immediat  reasons
that explain the changes detected in renal structure and
functio in old human beings or animals. How ver, these
studies have not established a relationship between the
specific mechanisms studied and the aging process. In
consequence, a second set of studies or hypotheses have
tried to establish  c sual link between the aging process
itself and the possible mechani ms involved in the g nesis
of th  renal changes. In this second part of this discussion,
I will focus on mechanisms responsible for aging-related
morphologic and functional renal changes, and links be-
tween the aging phenome o  and these mechanisms.
Morph logic. Aging-related morphologic renal changes
are s milar o those detected in renal disease and experi-
mental models characterized by progressive chronic renal
failure, including glomerulonephritis, diabetes, and surgical
reduction of renal mass [43J. Althoug  the exact biochem-
ical composition of the expan ed cxtrace lular matr x in
aging kidneys is not fully comparable o that i  any of those
pathologic situations [19], one could hypothesize th t aging
shares some of the pathog netic mechanisms pr posed for
th se disea es. Table 3 lis s the most widely accepted
mechani ms of extrace lular matri  expansio  and changes
in cell numbers in the kidney in progressiv  renal diseases.
Some of th se mechanisms have been widely explored in
experimental models of glomerulonephritis or diabetes, as
well as in rats with surgical renal mass reduction [43—48].
Four main aspects of the table must he str ssed. First, the
number of cells t  particular time in di ase progression
is regulated by the balanc  between cell proliferatio  and
a optosis (programmed cell death). Second, increased cell
numbers can pr c de glomerulosclerosis and interstitial
fibrosis, ve in situations in whi h cell proliferation is not
readily detected. Third, changes in the complex equilibrium
Table 3. Mechani ms and factors in olved in the expansion of
extraceflular matrix and changes in cell numbers in
p ogressive renal di ases
General mechani ms
Changes in the proliferation rate of resident or infiltrating cells
Changes in the ap ptosis rate of r sident or infil rating cells
Incr ased synthesis f normal or abnormal extracellular matrix
components
D creased degr dati n of normal or abnormal extracellular matrix
components
Factors in olved in the regulati n of these mechani ms
Growth factors: PDGF, EGF, TGFP, FGF, lGF-1
Cytokines lI-I, 1-13, TNF
V soactiv  peptides: Alt, ET, ANP
Lipid mediators: PGE2, PGI, 2, PAF
Others: NO, ROt
Abbreviations: PDGF, platelet-derived growth factor; EGF, epidermal
growth factor; TGF, transforming growth factor j3; GF, fibroblastic
growth factor; IGF.1, insu in-like growth factor ; 11-1, int rleukin-1; 1-13,
interleukin-13; TNF. tumor necrosis factor; All, angiote sin IL; ET.
endothelin; ANP, tri l nat uretic ptide; PGE2, prost gla din E2;
PGI,, prostacyclin;TxA2, thromboxane A2; PAF, platele -activating fac-
tor; NO, nitric oxide; ROt, reactive oxyge  intermediates.
between matrix synthesis and degr dation are, perhaps, the
main critical point in fibrosis d velopment. Fourth, from a
functional point of view, a wide overlap exists between the
classical growth factors and different vasoactive factors, as
the former may induce significant hemodynamic ffects,
whereas the latter may modif' the rate of proliferation and
protein synthesis in different cells.
These mechani ms hav  been scarcely explored in aging.
The number of niesangial cells increases in the early stages
of aging in rats [ 71, but no additional studies have con-
firmed this finding. It would b  very important to assess the
rates of proliferation and a optosis of the different renal
cell  s a function of age to ascertain the importance of
these phenomena in the g nesis of the progressiv  replace-
ment of cells by extrace lular matrix. In addition, glomer-
ular hypertrophy frequently occurs in elderly individuals
and old rats [12— 4]. Althoug  this hypertrophy has been
frequently considered the consequence of intrarenal hemo-
dynamic changes some authors b li ve that t e hyper-
trophy depends on th  rel ase of local mediators, including
growth factors [50], and that it could be a  indirect ma ker
of the increased local production of growth-promoting
metabolites. Only on  recent report h s nalyzed th  l vels
f one of these growth factors in lderly ndividuals. Chou
et al demons rated a  invers  relationship between urinary
epidermal growth factor excretion and age, and sugg sted
th t a reduced production of this growth factor retards the
repai  process at the kidney l vel [51. In contrast, different
vasoactive autacoids have been studied as possible media-
tors of the functional changes of the aging kidney, and it is
now a well-recognized fact th t autacoids regulat  cell
proliferation and/or extracettular matrix synthesis. Thus,
angiote sin IL and endothelin have well-defined ffects on
cell proliferation, whereas n tric oxide (NO) and atrial
natniuretic peptidc (ANP) possibly nhibit cell growth and
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FIg. 4. Expression of the TGF- mRNA in the
renal cortex from 3-month-old, 18-month-old,
24-month-old, and 30-month-old rats. Upper
panel, the simultaneous amplification of the
TGF-1 and GAPDH (housekeeping gene)
mRNAs by using RT-PCR, in samples from
rats of different ages. Lotver panel, the ratio
between the two amplification products (TGF-
131/GAPDH) were calculated and the mean
SEM of 6 different rats are given. P < 0.05
versus 3-month-old rats. (Published with
permission of! Am Soc Nephrol.)
extracellutar matrix synthesis [441. Changes in these vaso-
active, growth-promoting metabolites could be involved in
the development of the aging-related morphologic changes.
I will return to this topic. Finally, data about the possible
importance of the extracellular matrix degradation in the
genesis of the structural changes related to agthg have been
provided by Schaefer et al [52] and Reckeihoff et al [53],
who found that glomerular and tubular proteinase activities
decreased in aging rat kidneys. According to the previously
discussed criteria, the possible consequences of this de-
creased proteinase activity would be increased extracellular
matrix and subsequent morphologic changes in the kidney.
Some of these mechanisms are likely influenced by
gender, an important determinant of the rate at which the
kidney is damaged with age. Morphologic alterations are
less severe in old women than in old men [12, 13), and male
rats have a higher mortality rate due to renal failure [16].
These gender differences seem to depend on the presence
of androgcns rather than on the absence of estrogens;
castration of older animals prevented the development of
renal dysfunction in male rats without modifying the pat-
tern of renal damage in female rats [161.
Studies from our laboratory suggest that TGFf3 is in-
volved in the development of aging-related morphologic
changes, particularly interstitial fibrosis [20]. Using semi-
quantitative reverse transcriptase-polymerase chain reac-
tion techniques, we demonstrated that exprcssion of TGFf3
mRNA in renal cortex of Wistar rats increased progres-
sively with aging (Fig. 4). The blockade of TGFf3 expression
by long-term treatment with captopril partially prevented
the development of interstitial fibrosis but not of glomeru-
losclerosis. One of the growth factors most widely studied
for its role in the structural changes in different pathologic
conditions, TGFf3 modulates the proliferation rate of dif-
ferent renal cell types, as well as matrix synthesis and
degradation. Thus, the progressive glomerulosclcrosis as-
sociated with experimental glorneruloncphritis, diabetes, or
renal mass reduction could depend on TGFf3 niRNA
overexpression [48]. We expected to find significant
changes in this growth factor in our experiments in old rats.
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Although we demonstrated a direct temporal relationship
between aging and TGFI3 mRNA expression 2O1, only
interstitial fibrosis seemed to depend on this overexpres-
sion, in contrast with previous results in other pathologic
situations. Perhaps, as suggested by Abrass et al [19), the
nature and pathogenesis of aging-related renal dysfunction
are not fully comparable to those of glomerulonephritis,
diabetes, or renal mass reduction.
Functional. Aging-related functional changes are closely
related to the morphologic alteFations previously described.
However, they are not only the consequence of structural
changes, as a deranged regulation of different aspects of
normal renal function also seems to be involved in the
genesis of these changes. Moreover, a complex network of
functional relationships between the different renal struc-
tures exists, and changes in the function of a particular
structure can depend on the dysfunction of others.
Renal vessels in healthy elderly humans or rats do not
show structural changes significant enough to completely
explain the reduction in RBF, except when other patho-
logic situations such as arteriosclerosis are superimposed
on the basic aging process. In consequence, authors have
looked for the intrinsic causes of the decreased renal
plasma flow in the disease-free elderly individual. It is
generally accepted that the basic defect in the vessels of
these individuals is an impaired ability to relax in the
presence of some well-defined vasorelaxant stimuli. From
the initial description of decreased renal vasodilation after
pyrogen injection in human beings 4 decades ago, authors
have demonstrated, in human beings or in animals, that the
normal vasodilatory responses induced by acetylcholine,
amino acids, glycine, or after food ingestion are blunted in
the elderly [22, 24, 54]. However, some discrepancies exist
in this area. Hill and coworkers described a normal,
unblunted renal vasodilatory response to acetylcholine and
L-arginine infusion in older rats [55]. On the other hand,
the agonistinduced renal vasocontrictive response in the
aging kidney might not he the same in human beings and
rats. Hollenberg and colleagues demonstrated that the
angiotensin Il-induced reduction of RBF in elderly humans
was itidependcnt of the age of the subjects (221, and the
renal vasodilatory response to acute angiotensin converting
enzyme inhibition persisted even in old people [561. In
contrast, Tank et al found that kidneys of aged rats
exhibited an exaggcrated response to systemic vasoconstric-
tor stimuli [261. Taken together, these data suggest that the
combination of defective vasodilatjon with normal or in-
creased vasoconstriction accounts for the reduced RBF
that characterizes aging.
The basis for these altered vascular responses in the
aging kidney is not understood. Pyrogen injection, acetyl-
choline, and amino acid infusion share a common mecha-
nism of inducing renal vessel relaxation, that is, the local
retease of NO, one of the most important vasodilator
mechanisms. Defective synthesis or activity of the NO
system might be involved in the impaired renal vascular
vasodilator response observed in old individuaLs. Three
mechanisms could account for this possible defective re-
sponse: reduced production of NO in response to different
stimuli, increased degradation of the NO released, or
increased synthesis of this metabolite with a decreased
response of the target cells. The first of these three
hypotheses is supported by the fact that the 24-hour urinaly
excretion of nitrites plus nitrates (considered an indirect
index of NO synthesis in the kidney [57]) as well as the
glomerular synthesis of nitrites [58] are decreased in older
rats. However, in studies of aged Fats with NO synthesis
blockade, Reckeihoff and Manning demonstrated that the
dependence of renal blood flow on nitric oxide is greater in
old than in young individuals. They suggested that in-
creased synthesis of this compound is necessary to maintain
renal perfusion [251. As a conscquence of the increased and
maintained basal NO synthesis, the response to stimuli such
as acetylcholine or amino acids would decrease. Unfortu-
nately, neither direct measurements of local NO synthesis
in renal vessels nor a detailed analysis of the expression and
activity of NO synthases in renal cortex is available at
present. However, a report from Hwang et al demonstrated
that cultured proximal tubule epithelial cells from kidneys
of old donors express significantly higher amounts of
constitutive NO synthase [59]; this report opens new per-
spectives in the study of this problem. The reasons for a
possible increase of basal NO synthesis in renal cortex of
the aging kidney are unclear. Nitric oxide could act as a
counteracting mechanism of some vasoconstrictor media-
tors that might be increased in aging. High circulating
endothelin levels have been described in plasma of aging
men [60], endothelin mRNA expression is increased in
cultured vascular endothelial cells from old compared with
young individuals [61], and increased endothelin-1 secre-
tion was detected in aged cultured human umbilical vein
endothelial cells [62]. Endotlielin, via its ET-B receptor,
might increase NO synthesis. Our group, in collaboration
with the Department of Pathology of the University of
Granada, has found that mRNA expression of preproen-
dothelins I and 3 increases in old rats (unpublished data)
(Fig. 5); this work thus supports a possible role for this
peptide in the vascular renal changes that characterize
aging.
Nitric oxide and endothelin are not the only vasoactive
systems that have been studied as possible mediators of
aging-related functional changes. Impaired arterial harore-
flex, with a subsequent increased renal sympathetic activity,
has been proposed as a possible mechanism for increased
renal vascular resistance [54]. The previously mentioned
data concerning renin synthesis in elderly human beings
and rats [39—41] would lead us to expect that angiotensin II
decreases with aging, and some studies support this con-
tention [41]. However, one recent report proposing that
this peptide actually increases with age [63], and the
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Although we demonstrate  a direct tempo al relationship
between a ing and TGFI3 mRNA expression (201, only
interstitial fibro is se med to depend on this overexpres-
sio , in contrast with previous results in other pathologic
situations. Perhaps, as sugg sted by Abrass et al [19), the
nature and pathogenesis of a ing-related renal dysfunction
are not fully comparable to those of glomerulonephritts,
diabetes, or renal mass reduction.
Functional. A ing-related functional changes are closely
related to the morphologic alterations previously described.
However, they are n t only the consequence of str ctural
changes, s a deranged regulati n of different aspects of
normal renal function al o seems to be in olved in the
genesis of these changes. M reover, a complex network of
functional relationships between the different renal struc-
tur s exists, and changes in the functi n of  particular
str cture can depend on the dysfuncti n f others.
Renal v s els in healthy lderly humans or rats d  not
show str ctural changes s gnificant enough t  completely
explain th  reductio  in RBF, except when other patho-
logic si uations such s arteriosclerosis are superimposed
on the basic a ing process. In consequence, authors have
looked for the intr nsic causes of th  d creased renal
plasma flow in the dis ase-fr e lderly individual. It is
generally acc pted hat the basic defect in th  v s els of
these individuals is an impaired abili y to relax in the
presence of some well-defined vasorelaxant stimuli. From
the initial descripti n of d cr ased renal vasod lation after
pyroge  injectio  in human beings 4 decades ago, authors
hav  demonstrated, in human beings or i  animals, hat the
normal vasodilato y responses induced by acetylcholine,
amino acids, glycine, or after food ingestion are blunted in
the lderly [22, 24, 54]. However, some discrepancies exist
in this rea. Hill and c workers described a normal,
unblunted renal vasodilatory response to acetylcholine and
L-arginine infusio  in older rats [55]. On the other hand,
the agonist.induc d ren l vasocontrictive response in th
a ing kidney might not be the same in human beings and
rats. Hollenberg and colleagues demonstrated hat the
angiote sin II- induc  reduction of RBF in elderly humans
was independent of the age of the subjects (221, and the
renal vasodilatory response to acute angiote sin converting
enzyme inhibition persist d eve  in old people [561. In
contrast, Tank et a! found that kidneys of aged rats
exhibited an exaggerated response to systemic vasoconstric-
tor stimuli [261. Taken tog ther, these data suggest hat the
combinati n of defecti e vasod lation with normal or in-
cr ased vasoconstriction accounts for th  reduced RBF
hat characterizes a ing.
The basis for these altered vascular responses in the
a ing kidney is not understood. Pyrogen injection, acetyt-
choline, and amino acid infusion share a common mecha-
nism of inducing renal v ss l relaxation, hat is, the local
release of NO, one of the most impor ant vasodilator
mechani ms. Defective synthesis or activity of the NO
syste  might be in olved in the impaired renal vascular
vasodilatory response observed in ol  in ividuals. Three
mechani ms could account for this possibl  defective re-
sponse: reduced producti n of NO in response to different
stimuli, increased degradati n of the NO released, or
incr ased synthesis of this metabolite with a d cr ased
response of the target cells. The first of these three
hypotheses is supported by the fact hat the 24-ho r urinaly
excreti n of nitrites plus nitrates (considered a  indirect
index of NO synthesis in the kidney [57]) as well as the
glomerutar synthesis of nitrites [58] are decr ased in older
rats. However, in studies of aged rats with NO synthesis
blockade, Reckelhoff and Ma ning demonstrated hat the
dependence of renal blood flow on nitric oxide is greater in
old tha in young individuals. They sugg sted hat in-
cr ased synthesis of this compound is necessary to maintain
renal perfusion [25). As a consequence of the incr ased and
maintained basal NO synthesis, the response to stimuli such
s acetyicholine or amino acids would d crease. Unfortu-
nately, neither direct measur ments f local NO synthesis
in renal v ssels nor a detailed analysis of the expressio  and
activity of NO synthases in renal cortex is av i able at
present. However, a repo t from Hwang et at demonstrated
hat c ltured proximal tubule epithelial cells from kidneys
f old d nors express s gnificantly igher amounts of
constitutive NO synthase [591; this rep rt ope s new per-
spectives in the study of this problem. Th  reasons for a
possible incr ase of basal NO synthesis in renal cortex of
the a ing kidney are unclear. Nitric oxide could act s a
counteracting mechanism of some vasoconstrictor media-
tors hat might be incr ased in a ing. High irculating
endothelin levels hav  been described in plasma of a ing
men [60], endothelin mRNA expression is incr ased in
cultured vascular endothelia  cells fr m old compared with
young ndividuals [61], and incr as d endothelin-l s cre-
tion was de cted in aged c ltured human umbilical vein
endothelial cells [62]. Endothelin, via its ET-B receptor,
might incr ase NO synthesis. Ou  group, in collaboration
wit  the Department of Pathology of the University of
Granada, has found hat mRNA expressi n of eproen-
dothelins I and 3 increases in old rats (unpublished data)
(Fig. 5); this work thus supports a possible role for this
peptide in the vascular renal changes hat characterize
a ing.
Nitric oxide and endothelin are not the only v soactive
systems hat hav  been stu ied as possible mediators of
a ing-related functional changes. Impaired arterial barore-
flex, with a ubseque t incr ased renal sympa heti  ac ivity,
has been roposed s a possible mechanism for incr ased
renal vascular resistance [54]. The previously mentioned
data concerning renin synthesis in lderly human beings
and rats [39—4 1] would lead us to expect hat angiote sin 11
d cr ases with a ing, and some studies support this con-
ention [411. However, one recent repo t roposing hat
this eptide actually increases with age [63], and the
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Fig. 5. Northern blot analysis of the expression of the preproendothelin-1 and GAPDH (housekeepinggene) mRNAs in 3-month-old and 24-month-old
rats.
significant renal vasodilalion with increases in renal plasma
flow observed in older rats in response to the acute
angiotensin II blockade [64], suggest that intrarenal anglo-
tensin 11 is activated in senescent rats. Synthesis of platelet
activating factor (PAF), a lipid mediator with well-recog-
nized vasoconstrictor ability, seems to be increased in
isolated glomeruli of aged rats [31J; this finding suggests a
pathogenetic role for this autacoid in aging-induced altered
vascular responses. The equilibrium between prostacyclin
and thromboxane also is deranged with aging, and the ratio
of prostaglandin 12 to thromboxane A2 decreases in the
urine of older humans, as well as in the glomeruli and inner
and outer medulla of older rat kidneys 162, 65]. Finally,
impaired ANP-induced relaxation of renal arteries in rats
and monkeys 166] provides yet another way of impairing
renal vasodilation.
Another possible explanation for the impaired renal
vasodilatory response is defective activation of intracellular
second messengers that mediate vascular smooth cell re-
laxation. A blunted cAMP response to 3-adrenergic ago-
nists has been described in blood vessels with aging, and
Lakatta has proposed that this alteration modifies vascular
responses to stress and exercise [67J. Further study reveals
that this response could depend on impaired guanine
nucleotide regulatory protein (0 protein) function [68].
However, it was not possible to detect changes in the
amount of these G proteins in aged rats, particularly Gs
and Gi, at the renal level [69]. On the other hand, the
defective response to ANP in blood vessels from elderly
individuals might be due to accelerated degradation of
cGMP by phosphodiesterases [661. Additional studies arc
needed, including evaluations of the different intracellular
systems involved in vascular smooth muscle cell relaxation,
to clarify the importance of these mechanisms in the
development of aging-related decreased renal plasma flow.
Changes in GFR in the elderly are generally attributed to
progressive glomerular sclerosis and decreased renal
plasma flow. However, formation of the glomerular ultra-
filtrate is a finely regulated phenomenon, and the reduction
in GFR occurs more slowly than does the fall in RPF, the
result being an increased filtration fraction. Two mecha-
nisms might account for the relative GFR maintenance,
even in the presence of significant hemodynamic and
structural changes. First, as I said before, the aging process
produces a non-homogeneous derangement of renal blood
flow, with a preferentially decreased cortical flow [22j. As
the filtration fraction of the juxtamedullary glomeruli
seems to be higher than that of the cortical glomeruli, the
GFR would diminish less than in the case of a homoge-
neous reduction in renal perfusion. Second, it is well known
that the remaining glomeruli undergo hemodynamic
changes to compensate for the lack of function of the
sclerosed glomeruli [49]. This phenomenon, known as
secondary hyperfiltration, could maintain adequate GFR
even in the presence of a significant reduction of function-
ing nephrons. The mechanisms involved in the develop-
ment of hyperfiltration have been extensively studied in
different experimental models. In most cases, hyperfiltra-
tion seems to depend on increased glornerular plasma flow
and increased hydrostatic pressure in the glomerular cap-
illary network as a consequence of selective vasodilation of
the afferent arteriole [491. Micropuncture studies in aged
rats have analyzed the determinants of glomerular ultrafil-
tration. Most of these studies demonstrate decreased resis-
tance of the glomerular afferent arteriole with an increased
glomerular plasma flow [25—27]. Controversy exists, how-
ever, with respect to changes in the glomerular capillary
pressure in these old rats, because normal [16, 25, 27] or
increased values [701 have been detected. Moreover, an
increased age-related ultrafiltration coefficient also has
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been described [25, 27]. A recent micropuncture study by
Baylis, performed in Munich-Wistar rats, failed to demon-
strate the previously described changes in old rats, as
glomeruktr plasma flow decreased and afferent arteriole
resistance increased, whereas the ultrafiltration coefficient
did not change [161. This study points to a possible inter-
strain variability in the mechanisms involved in the devel-
opment of aging-induced GFR changes. In any case, we
must remember that these studies were performed in rats
as old as 2 years, when glomeruloscierosis and proteinuria
are readily detected [15] but when absolute values of GFR
are maintained [16, 24].
As in the case of RBF, changes in GFR in the elderly
might be due, at least partially, to an imbalance among the
autacoids that regulate intraglomerular hemodynamics.
However, no studies have analyzed independently these
possible local mediators. As regulation of intraglomerular
hemodynamics depends on the regulation of the afferent
and efferent arterioles, the autacoids Involved could be the
same in both processes. But additional studies are needed
to clarify the specific mediators that lead to the reno-
vascular and gomerular changes of aging.
What accounts for the relative inability of elderly indi-
viduals to reabsorb sodium normally? First, aging-associ-
ated structural renal alterations, such as interstitial fibrosis
or a decreased number of tubules, might play a part in the
homeostasis. Second, decreased GFR and its attendant
hyperfiltrating glomeruli also might explain some aspects of
the deranged sodium homeostasis. Thus, a decreased GFR
could produce, on a short-term basis, a relative inability to
excrete a sodium load. On the other hand, the hyperfilter-
ing nephrons excrete a solute load significantly higher than
do normal nephrons, with a subsequent osmotic diuresis
and natriuresis; these hyperfiltering nephrons are unable to
readily reabsorb sodium. Third, hormonal changes also
might account for changes in sodium homeostasis. When
plasma aldosterone was measured in elderly individuals,
values were significantly lower than those in young people
[71]. This decreased adosterone synthesis could contribute
to the relative inability of the aging kidney to conserve
sodium. The hormone proposed to account for this de-
ranged sodium excretion is ANP; plasma levels of this
hormone significantly increase in elderly subjects [72].
However, the natriuretic response after the infusion of
exogenous ANP seems to be decreased in healthy elderly
men [73. These data have been interpreted as a relative
decreased responsiveness of the aging kidney to ANP.
Decreased concentrating ability in the elderly has been
attributed to changes in the functional status of the hypo-
thalamic-pituitary axis. However, when the release of argi-
nine vasopressin (AVP) was analyzed under different phys-
iologic stimuli, elderly subjects exhibited increased AVP
release with respect to young individuals [741. Not all
studies have had similar results, however, and decreased
aging-related AVP release also has been demonstrated
[75]. Moreover, non-osmotic AVP release also might be
deranged in the elderly [74. 75}. In any case, it is generafly
accepted that the most important mechanism involved in
the elderly's renal concentrating defect is an inadequate
renal response to endogenous AVP. In humans. this lack of
response has been attributed to aging-related tubulointer-
stitial structural changes as well as to a derangement in the
intrarenal mechanisms responsible for the maintenance of
medullary hypertonicity, induding solute transport by the
thick ascending limb of the loop of 1-lenle and relatively
slow medullary blood flow [22, 33]. Studies in rats also
suggest that impaired responsiveness of the collecting duct
cells to AVP is involved in the concentrating defect ii old
animals. The basis of this defect cou'd be a decreascd
number of V2 receptors, hut a recent report failed to
demonstrate such a decrcase. In consequence, defective
coupling of this receptor to the adenylate cyclase system
likely explains the lack of response to AVP in older rats [76.
77]. The intrinsic mechanisms of the rena' diluting defect in
the elderly have been less studied, hut they might relate to
the aging-related decrease in GFR and decreased solute
transport in the thick ascending limb of the 'oop of Hene.
Other aging.reiated tubular defects, including defective
renal acidification and phosphate management, have been
analyzed less extensively. Impaired acidification seems to
be a consequence of reduced renal mass [38], although
some studies suggest an intrinsic acidification defect, pos-
sibly associated with impaircd ammoniuni excretion [78].
Defective phosphate reabsorption by the proximal tubuk
partially depends on the increased PTH concentration
associated with decreased GFR [361. But parathyroidec-
tomy only partially prevents this defect, so alternative
mechanisms of deranged phosphate reabsorption must he
at play. Phosphate transport is decreased in cultured renal
tubular cells [79j, and Levi et a! have suggested that this
decreased transport results from changes n the chemicat
composition of cefl membranes [801. Moreover, the exprcs-
sion of the type-LI Na-Pi cotransporter decreases with age
in tubular cells [81].
Aging and activation of the mechanisms involved in the
renal changes in the elderly
As I stated before, most studies deafiug with the mech-
anisms involved in the development of aging-related mor-
phologic and functIonal renal changes have focused on a
particular deranged aspect of renal structure or function.
However, these studies have not provided enough clues
about how aging determines the activation of these mech-
anisms. For instance, some authors have proposed that
reduced RBF in elderly individuals depends on changes in
the local synthesis of NO [25, 75]. but we still do not know
how aging induces these changes. Our knowledge of the
general mechanisms of aging and of the direct mediators of
renal dysfunction may help us to better understand the
aging process at the renal 'eveL
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been described [25, 27]. A recent micropuncture stud  by
Baylis, performed in Munich-Wistar rats, failed to demon-
s ra e the previously described changes in old rats, as
glomerular plasma flow decreased and afferent arteriole
resistance incr ased, whereas the ultrafiltration coefficient
did not change [16]. This study points to a possible inter-
strain v riability in the mechanisms involved in the d vel-
opment of aging-induced GFR changes. In any case, we
must re ember that th e studies wer  pe formed in rats
as old as 2 years, when glomerulosclerosis and proteinuria
a  readily de cted [15] but when absolute values of GFR
are maintained [16, 24].
As in the case of RBF, changes in GFR in the lderly
might be due, at least partially, to an imb lance among the
autacoids that regulate intraglomerular hemodynamics.
However, no studies have nalyzed ind pendently th se
possible local mediators. As regulation of intraglomerular
hemodynamics d pends on th  regulati n of the afferent
and fferent a terioles, the utacoids involved could be the
same in both proces es. But additional studies are ne ed
to clarify the specific mediators that lead to the reno-
vascul r and glomerular changes of aging.
Wh t accounts for the relat ve inability of lderly ndi-
viduals to reabsorb sodium normally? First, a ing-associ-
ated str ctural ren l alterations, such as interstitial fibrosis
or a decreased number of tubules, might pl y  part in the
homeostasis. Secon , decreased GFR and its attendant
hyperfiltratin  glomeruli also might explain some aspects of
the deranged sodium homeostasis. Thus, a decreased GFR
could produce, on a short-term basis, a relat ve inability to
excrete a sodium load. On the other hand, t e hyperfilter-
ing nephrons excrete a solute load significantly igher than
do normal nephrons, with a subsequent osmotic diuresis
a d nat iuresis; these hyperfiltering nephrons are unable to
readily reabsorb sodium. Third, hormonal changes also
might account for changes in sodium homeo tasis. When
plasma aldosterone was measured in e derly individuals,
values were s gnificant y lower than those in young people
[71]. This decreased aldosterone synthesis could contribute
o th  relative inability of the aging kidney to conserve
sodium. The hormone pr posed to account for this de-
ranged sodium excretion is ANP; plasma l vels of this
hormone significantly increase in elderly subjects [72].
How ver, the natriuretic response after the infusion of
exogenous ANP seems to b  d cr ased in healthy lderly
men [73]. Th se data have bee  interpreted s a relative
decreased responsiveness of the aging kidney to ANP.
Decreased co centrating ability in the elderly has been
attributed to changes in the functional status of t e hypo-
thalamic-pituitary axis. However, when the r lease of argi-
nine vasopressin (AVP) was nalyzed under diff rent phys-
i logic stimuli, elderly subjects exhibited increased AVP
release with respect t  you g individuals [74]. Not all
studies have had similar results, how ver, an  decreased
aging-related AVP r lease also has been demonstrated
[75]. Moreover, non-osmotic AVP r lease also might be
deranged in the lderly [74, 75]. In any case, it is generally
acc pted hat the most impor ant mechanism in olved in
the elderly's renal concen rating d fect is a  inadequate
renal response to endogenous AVP. In humans. this lack of
response has been attributed to a ing-related tuhulointer-
stitial structural changes as well as to a derang me t in the
intrarenal mechanisms responsible for the mainte ance of
medullary hypertonicity, including solute transport by the
thick asce ding limb of the lo p of Henle and relatively
slow medullary blood flow [22, 33]. Studies in rats also
suggest hat impaired responsiv ness of the collecting duct
cells to AVP s involved in the concen rating defect in old
animals. The basis of this d fect could he a decreased
number of V2 receptors, hut a r cent report failed to
demons rate such a decrease. In consequence, defective
coupling of this receptor to the adenylate yclase ystem
likely explains the lack of response to AVP in older rats [76,
77]. The intrinsic mechanisms of th  renal diluting d fect in
the elderly have been le s stu ied, hut they might rela e to
the aging-relate  decrease in GFR an  decreased solute
transport in the thick ascending limb of the loop of Henle.
Other aging-related t bular defects, including defective
ren l acidification and phosphate management, have been
nalyzed less xtensively. Impaired acidification seems to
be a consequence of reduced renal mass [38], although
some studies suggest an tr nsi  acidification d fect, pos-
sibly associated with impaired ammo um excretion [78].
D fective phosphat  reabsorption by the proximal t bule
partially depends on the increased PTH concen ration
associated with decreased GFR [361. But parathyroidec-
tomy only partially prevents this d fect, so alternative
mechani ms of deranged phosphat  reabsorption must he
at play. Phosphate transport is decreased in c ltured renal
t bular cells [79], and Levi et a! have suggested that this
decreased transport results from changes in the chemical
composition of cell membranes [801. Moreover, the expres-
sion of the type-LI Na-Pi cotransporter decrea es with age
in t bular cells [81].
Aging and activation of the mechanisms involved in the
renal changes in the elderly
As I stated before, most studies dealing wi  the mech-
ani ms involved in the d velopment of aging-related mor-
phologic and functional renal changes have focused on a
particular deranged aspect of renal str cture or function.
How ver, th se studies have not provi ed enough clues
about how aging determines the activation of th se mech-
anisms. For instance, some authors have pr posed that
reduced RBF in elderly ind viduals depends on changes in
the local synthesis of NO [25, 75]. but we still d  not know
how aging induces th se changes. Our knowledge of the
g neral mechani ms of a ing and of the direct mediators of
renal dysfunction may help us to b tter understand the
aging process at th  renal level.
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Alterations in the genetic program, induced by turning
on the cell death program (apoptosis) or by exogenous
damage to DNA may explain the activation of particular
pathogenetic mechanisms in the aging kidney. Thus.
changes in the synthesis of certain growth factors, vasoac-
live mediators. or cell transporters might be associated with
the genetic changes that induce aging Unfortunately, a
detailed analysis of the genetic changes in senescent kidncy
cells, unlike in senescent fibroblasts [1], has not been
performed.
One attractive hypothesis might explain how the kidney
ages. Anderson and Brenner suggest that aging-related.
progressive renal damage is the consequence of a continu-
ous exogenous stimu)us, the diet, on renal structure and
function [49]. This hypothesis supports the general niech-
anisms of aging that I atready discussed. Long-term low-
protein feeding and chronic angiotensin II converting-
enzyme inhibition have a protective effect on the
glomerulus in the aging rat [15, 49, 7O1 Because these two
maneuvers lower intraglomerular pressure in other exper-
imental models of renal disease, these data have been
interpreted as indicating that glomeruar hypertension,
induced by a high-protein diet, causes age-induced ne-
phropathy. The mechanisms connecting intraglomcrular
hypertension with progressive damage of glomerular struc-
tures are currently being investigated, and it seems that
changes in the mechanical forces acting on the cells might
induce significant phenotypic changes in resident glomeru-
lar cells, thereby modulating the release of local mediators
[82, 83].
The critical point for validating this theory would be the
direct demonstration of increased iniraglomerular pressure
in elderly experimental animals. Anderson et al reported
increased intraglomerular pressure in 24-month-old Mu-
nich-Wistar rats [70]. However, Baylis did not find signifi-
cant changes in glomerular pressure in males up to 20
months of age of the same rat strain, even though the
animals had significant glornerular structura' damage [16].
Moreover, intraglomcrular pressures in castrated male and
Fig. 6 Northern blot analysis of the changes
in the preproendothclin.I niRNA expression In
cultured boine aortic endotheflni ceH
incubated with hydrogen peroxide (100 ELM) for
different times (4 to 24 hours).
in female Munich-Wistar rats, which do not develop gb-
nieruloscierosis, did not differ from values in intact male
rats [16]. Other rat strains that develop glomerulosclerosis
earlier, for example, Sprague-Dawley, show small increases
of intragbonierular pressure at 13 to 18 months but not at 20
to 22 months of age [25]. All these data suggest that
intragloinerutar hypertension is a relevant, but not the sole,
factor in aging-related renal damage. Nor is it likely the
initial mechanism that triggers progressive renal dysfunc-
tion in the elderly.
Reactive oxygen intermediates also might be a link
between aging and renal damage. The first argument
supporting a role for ROl in the progressive renal damage
of aging comes from the observation that these metabolites
likety are involved in the pathogenesis of other renal
diseases characterized by progressive extracellular matrix
expansion and decreased GFR, such as experimental renal
mass reduction or glomerulonephritis [84]. Moreover, the
cellular biology of resident glomerular cells is clearly
influenced by ROl. Although high concentrations of these
metabolites usually induce cell necrosis, under particular
experimental conditions, they induce proliferation of mes-
angial cells [851. This fact could be related to tyrosine
phosphorylation of the platelet-derived growth factor re-
ceptor and the pp6Oc-src protein [86]. Further, ROl pro-
mote changes resembling apoptosis in tubular cells [87]. By
promoting cell proliferation or apoptosis, ROl might play
different pathogenetic roles during different stages of
aging. In early stages, increased cell proliferation associ-
ated with increased synthesis of extracellular matrix might
induce matrix expansion. in more advanced stages, apopto-
sis could reduce the number of cells in different parts of the
nepliron as well as in the interstitium.
Reactive oxygen intermediates also might modulate syn-
thesis of the vasoactive factors involved in the dysfunction
of the aging kidney. Reactive oxygen intermediates in-
crease prostanoid synthesis in varying renal structures [84].
Moreover, PAF synthesis by inesangial cells also might be
increased in the presence of ROl [88]. In addition, ROt
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Fig. 7. Northern blot analysis of the changes in the endothellal consti-
tutive nitric oxide synthase (NOS-3) nRNA expression (upper panel) and
in the activity of this enzyme, measured as the conversion of arginine to
citrulilne (lower panel), in cultured bovine aortic endothelial cells incu-
bated wIth xanthlne (X, 0.1 M) plus xanthlne oxidase (XO, 1 mU/mI) for
different tImes (4 to 24 hours).
stimulate endothelin production in cultured human mesan-
gial cells [89]. In our own laboratory, expression of pre-
proendothelin-1 mRNA increased in cultured bovine aortic
endothelial cells incubated with hydrogen peroxide (Fig. 6)
[90]. The relationships between NO and ROt are less well
documented. Superoxide anion may inactivate NO, thereby
inhibiting this vasodilatory system [91]. However, recent
results from our laboratory point to alternative possibilities
[92]; messenger RNA expression of one of the enzymes
involved in NO synthesis, thc endothelial constitutive nitric
oxide synthase, as well as its activity, might be increased in
cultured bovine aortic endothelial cells incubated with a
RU! generating system such as xanthine-xanthine oxidase
(Fig. 7). The relationship between these in-vitro findings
and the in-vivo results in aged individuals must be evalu-
ateci carefully in the future.
Data concerning the ability of ROl to modulate cytokine
synthesis by different glomerular cells are scarce. Synthesis
of tumor necrosis factor seems to be stimulated by ROl
[93], and deferoxamine, an iron chelator with well-defined
antioxidant properties, might regulate tumor necrosis fac-
tor release in mesangial cells [94]. On the other hand, ROl
might be an intermediate metabolite in the release of
nionocyte chernoattractant protein and monocyte colony-
stimulating factor induced by tumor necrosis factor [95].
The possible role of these cytokines in the aging kidney has
not been studied.
Two recent reports from our laboratory stressed the
importance of ROT in the pathogenesis of the changes that
characterize the aging kidney. in the first of these studies.
we demonstrated increased ROt synthesis by isolated gb-
meruli and cultured mesangial cells from old rats, aswell as
increased oxidative damage in the renal cortex of these
animals [31]. In the second, probucol, a drug with antioxi-
dant properties used for hypercholesterolemia, prevented
protein accumulation in the glomeruli of aged rats without
modifying cholesterol levels [96]. These data indicate that
increased age-related ROl synthesis induces well-defined
effects in different renal structures, and triggers the func-
tiona and morphotogic changes that characterize aging.
The role of AGEs in the development of diabetic com-
plications has been studied extensive'y [91. Increased in
elderly individuals 191, AGEs might induce some of the
changes involved in the development of aging-induced
rena( dysfunction. Receptors for AGEs have been de-
scribed in macrophages and monocytes [97j. These cells,
which transient(y infiltrate the renal parenchyma, might
synthesize interleukin-1, insulin-like growth factor 1, tumor
necrosis factor, and granulocyte-macrophage colony stim
ulating factor in response to receptor binding by AGEs
[98]. In addition, AGE receptors have been identified on
glornerular mesangial cells, where they seem to play a role
in the modulation of PDGF-induced extracellular niattix
synthesis [99]. Prolonged administration of AGEs to nor-
mal rats induced glomerular hypertrophy and extracellular
matrix expansion [100]; this finding underscores the impor-
tance of these metabolites in the development of glomer-
uloscierosis. Finally, the functional properties of several
important matrix components are a'tered by AGE fornia-
tion, disrupting the normal matrix-to-matrix and cell-to-
matrix interactions [101, 102j, thus favoring the progressive
matrix expansion of aging kidneys.
Before I finish this discussion, I would like to mention a
particular point of view regarding the pathogenesis of renal
dysfunction in the aging kidney. The finding that about
one-third of the subjects included in the Baltimore Longi-
tudinal Study of Aging did not show any change in the
glomerular filtration rate [281, and the existence of rat
strains that do not develop any aging-related renal damage
[1031, suggest that the renal dysfunction of thc elderly is
due to an accumulation of damage induced by minimal,
clinically undetected, renal disease, and is not the conse-
quence of the aging process itself. Although it is a well-
recognized fact that aged patients with superimposed dis-
eases, such as hypertension or diabetes, show a more rapid
decrease of renal function, healthy human beings and
laboratory rats with well-controlled disease develop these
renal changes in the absence of any detected renal disease.
It is likely that a complex relationship between external
influences, including diet, and the genetic program of a
particular individual determines the variability observed in
aging humans.
tric oxide synthas  ( nRNA expre sion
t ity of this enzyme, measure   i  inine to
ilne (lower p l , i  l  i  orti  dothei l ll  i
i tnt
fere t ti
[93], and f r i , 
I
  t sis f t e changes
ze 
li  lt  i l ll   l  t ,   s
I
     . ,
ll l r
atri  e a si  [ ]; this fi i  r r  t  i r-
 t
4Vephrnlogy Forum: The a.irg kidney 2259
250
1 NOS3 (4.5 Kb)
2000
U)>
U)
150
C.)
100
50
C 4hr 8hr
-XO (0.1 M—i mU/mi)
241w
Fig. 7. Northern blot nalysis of the changes in the endothe ial consti.
tutive nitric oxide synthase (NOS-3) nRNA expression (upper panel) and
in the ac ivity of this enzyme, measured as the conversion of argi ine to
citrulilne (lower panel), In c ltured bovine aortic endothe ial cells incu-
bated with xanthlne (X, 0.1 M) plus xanthlne oxidase (XO, 1 mU/mi) for
different times (4 to 24 hours).
stimulate endothelin productio  in c ltured human mesan-
gial cells [89]. In our own laboratory, expression of pre-
proendotheiin-1 mRNA increased in cultured bovine aortic
endothelial cells incubated wit  hydrogen peroxide (Fig. 6)
[90]. The relationships between NO and ROt ar  less well
documented. Superoxide anion may inactivate NO, th reby
inh biting this vasodilatory ystem [91]. How ve , r cent
results from our laboratory point to alternative poss bilities
[92]; messenger RNA expression of one of th  enzymes
involved in NO synthesis, the endothelial consti utive n tric
oxide synthase, as well as its act vity, might be increased in
cultured bovine aortic endothelial cells incubated with a
RU! g nerating ystem such as xanthine-xanthine oxidase
(Fig. 7). The relationship between th se in-vitro findings
and the in- ivo results in aged ind viduals must b  evalu-
ated carefully in the f ture.
D ta concer ing the ability of ROl to modulate cytokine
synthesis by diff rent glomerular cells are scarce. Synthesis
of tumor necrosis factor seems to be stimulated by ROl
[93J, and deferoxamine, an iron chelator with well-defined
antioxidant properties, might regulate tumor necrosis fac-
tor r lease in mesangial cells [94]. On the other hand, ROl
might be an intermediate metabolite in the r lease of
m nocyte chemoattractant protein and m nocyte colony-
stimulating factor induced by tumor necrosis factor [95].
The possible role of th se cytokines in the aging kidney has
not been studied.
Two r cent reports from our laboratory stressed the
importance of ROT in the pathog nesis of the changes that
ch racterize the aging kidney. in the first of th se studies.
we demonstrated increased ROt synthesis by isolated gb-
meruli and cultured mesangial cells from old rats, as well as
increased oxidative damage in the renal cortex of th se
animals [31]. In the second, probucol, a drug with antioxi-
dant properties used for hypercholesterolcm ia, pr vented
protein accumulation in the glomeruli of aged rats without
modifying cholesterol l vels [96]. Th se d ta indicate that
increased age-related ROT synthesis induces well-defined
effects in diff rent renal structures, and triggers the func-
tion l and morphologic changes that ch racterize aging.
The role of AGEs in the d velopment of diabeti  com-
plications has been studied extensively [91. Increased in
elderly individuals [9], AGEs might induce some of the
changes involved in the d velopment of aging-induced
renal dysfunction. Receptors for AGEs have been de-
scribed in macrophages and monocytes [97]. Th se cells,
which transiently infiltrate the renal parenchyma, might
synthesize int rleukin-1, insulin-like growth factor I, tumor
necrosis factor, and granulocyte-macrophage c lony stim-
ulating factor in response to r ceptor binding by AGEs
[98]. In addition, AGE r ceptors have been identified on
glornerular mesangial cells, wh re they seem to play a role
in the modulation of PDGF-induced extracellutar matrix
synthesis [99]. Pr longed adm nistration of AGEs to nor-
mal rats induced glomerular hypertrophy and extracel ular
matrix expansion [100]; this finding underscores the impor-
tance of th se metabotites in the d velopment of glomer-
uloscierosis. Finally, the functional properties of s veral
important matrix compo ents are alt red by AGE forma-
tion, disrupting the normal matrix-to-matrix and cell-to-
matrix interactions [ 0 , 102], thus favoring the progressive
matrix expansion of aging kidneys.
Before I f nish this discussion, I would like to mention a
particular point of view regarding the pathog nesis of renal
dysfunction in the aging kidney. The finding that about
one-third of the subjects inclu ed in the Baltimore Longi-
tudinal Study of Aging id not show any change in the
glomerular filtration rate [281, and th  existence of rat
strains that do not d velop any aging-related renal damage
[1031, suggest that the renal dysfunction of th  elderly is
due to an accumulation of damage induced by m nimal,
cl nically und tected, renal disease, and is not the conse-
quence of the aging process itself. Although t is a well-
recognized fact th t aged patients with superimpose  dis-
ea e , such as hypertension or diab te , show a more rapid
decrease of renal function, healthy human beings and
laboratory rats with well-controlle  disease d velop th se
renal changes in the absence of any d tected renal disease.
It is likely that a complex relationship between external
influences, including diet, and the g netic program of a
particular ind vidual d termines the variability observed in
aging humans.
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QUESTIONS AND ANSWERS
DR. JOHN T. HARRJNJTON(Dean. Tufts University School
of Medicine, Boston, Massachusetts, USA): Thank you,
Diego, for a wonderful summary and synthesis of a great
deal of data regarding aging of the kidney. My question is.
are rats a good model for these studies? Are there compa-
rable studies in mice, hamsters, or dogs?
DR. RODR1GUEZ-PUYOL: Most information has been ob-
tained in rats and mice, perhaps because of the wide
availability of these animals. But discrepancies do exist with
respect to the adequacy of the model. In contrast to human
beings, rats are characterized by the early appearance of
proteinuria and the maintenance of a normal GFR until
very advanced ages. In some rat strains, almost no changes
are detected in the kidney even in very old animals [103]. In
consequence, some authors beicve that rodents, particu-
larly rats, are not the most suitable model for studics of
aging. The available information about the aging phenoni-
enon in other animal models is scarce, and no definite data
point to a particular species as the best model for these
studies. In fact, efforts are underway to develop rat strains
that could constitute better models for analyzing aging
[104].
DR. HARRINGTON: My second question is more specific.
Can you block the production of mesangial matrix, specif-
ically taminin?
DR. RODR1GUEZ-PUYOL: Strategies for blocking mcsan-
gial matrix synthesis havc been directed to the blockade of
TGFp, as this growth factor is likely responsible for the
increased extracellular matrix observed in a variety of
pathophysiologic conditions. ACE inhibitors, anti-TGFp
antibodies. and decorin have been the most widely used
tools for blocking TGFp. To my knowledge, no studies
have been designed that specifically block larninin synthesis
in experimental models of renal disease, hccause this
matrix protein has not been considered as pathophysiologi-
cally relevant as collagens or uibronectin. The interesting
observations from Abrass and colleagues demonstrating
the accumulation of laminin in the glomerular basement
membrane of old rats suggest that this extracellular protein
plays a role in the genesis of the aging-related renal
changes [19]. In consequence, experiments directed at
specifically blocking particular laminin isofonns could pro-
'ide intcresting information regarding the mechanisms
involved in the aging process.
DR. ANGEL DE FRANCISCO (Professor of Nep/wolo, Uni-
versity Hospital "MarquEs tie Valdecilla," Santander, Spain):
I have a question concerning the hemodynamic actions of
ACE inhibitors in aging. Aging is accompanied by renal
vasoconstriction. Taking into account the importance of
angiotensin 11 in the regulation of renal blood flow, do you
believe that ACE inhibitors could be useful in preventing
the aging-related reduction in rcna blood flow?
DR. RODRJGUEZ-PUYOL: The importance of angiotensin
II in the aging-re'ated reduction in renal blood flow reduc-
tion is not known. Different experimental approaches, such
as measuring the circulating levels of renin or angiotensin
U or measuring the angiotensin 11 turnover, have provided
conflicting results r39—41, 63 64]. The conflicting results
arc not too surprising, as the critical question—the degree
of activation of the local renin-angiotensin system—cannot
be directly explored. When ACE inhibitors are used to
block the synthesis of angiotensin II, renal plasma flow in
older rats increases [64], thus suggesting that, at 'east
partially. renal vasoconstriction may depend on increased
local synthesis of angiotensin I! in rats. Young and old
human beings show a comparable hemodynamic response
to angiotensin 11 blockade [54, 64].
DR. MANUEL ARIAs (Head, Naphro1o' Department, Uni-
ve,ity Hospital "Marques de Valdecilla": We have some data
in patients with advanced chronic renal failure showing a
predominance of FAS and a decrement of bcl-2, a pattern
of increased programmed cell death. Do you have any
experience in the analysis of renal tissue for the apoptosis
genes? Do you think that apoptosis might be responsible
for aging of the kidney?
DR. RODR1GUEZ-PUYOL: That is a vcry interesting ques-
tion. We havc considered the hypothesis that a change in
the apoptosis rate is a pathogenetic mechanism in the aging
kidney. Using Northern blot analysis, we were unable to
detect changes in the mRNA expression of bcl-2, whereas
bax slightly but significantly decreased in the renal cortex
from old rats. However, these results are preliminary and
incomplcte, as bcl-2fbax are not the only the genes involved
in the regulation of apoptosis. Additional studies are
needed to adequately answer your question.
DR. Jose MARIA MORALES Assistane Profèssor of Medi-
cine, Hospital "12 de Octubre, "Madrid, Spain): Doyou have
information regarding cyclosporine's nephrotoxicity in ag-
ing kidneys?
Dg. R0DRIGuEz-PuYoL: As I said earlier, our group
believes that rcactive oxygen species seem to be involved in
the pathogeiiesis of aging-related renal changes. Moreover,
we have recently demonstrated that cyclosporine A in-
creascs the synthesis of ROS by cultured human mesangial
cells [105]. In consequence, it is possible that cyclosporine
A is more nephrotoxic in the elderly. The influence of age
in cyclosporine A-induced nephrotoxicity has been studied
in rats [106], but rats are not a good model for analyzing
cyclosporine-induced damage because the dose that must
be used to induce renal damage is much higher than the
usual doses in human beings (50 mg/kg/day). In patients
receiving a renal graft, cyclosporine A nephrotoxity does
not seem to be increased with increasing donor age [107].
To my knowledge, however, no clinical studies have been
designed to answer this question specifically. These studies
should be performed in patients with heart, liver, or lung
transplants. or in patients receiving cyclosporine because of
extrarenat diseases.
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QUESTIONS AND ANSWERS
DR. JOHN T. HARR NGTON (Dean. Tufts University School
of Medicine, B ston, M ssachu etts, USA): Thank you,
Dieg , for a wonderf l summary and synthesis of a great
deal of data regardin  a ing of the kidney. My question is.
are r ts a good model for these studies? Are there compa-
rable stud es in mice, ham ters, or dogs?
DR. RODR1GUEZ-PU L: t information has been ob-
tained in rats and mice, perhaps because of the wide
availability of these animals. But discrepancies do exist with
r spect to the adequacy of the model. In contrast to human
beings, r ts are characterized by the early appearance of
proteinuria and the mai tenance of a normal GFR until
very dvanced ages. In some rat strains, almost no changes
are detected in the kidney even in very old animals [103]. In
consequ nce, some authors believe that rodents, particu-
la ly rats, are not the most suitable model for studies of
a ing. The available information about the a ing phenom-
enon in other animal models is s arce, a d no definite data
point to  particular sp cies as th  best model for these
studies. In fact, efforts are underway to develop rat strains
hat could constitut  better models for analyzin  a ing
[104].
DR. HARRI GTON: My second question is mor  specific.
Can you block the producti n of mesangial matrix, specif-
ically laminin?
DR. 0DRIG Ez-PuYoL: Strategies f r blocking mesan-
gial matrix synthesis hav  been directed to the blockade o
TGF, as this growth factor is likely responsible for the
incr as d extracellular matrix obs rved in  variety of
pathophysiologic conditions. ACE inhibitors, anti-TGFf3
antibodies, and decorin hav  been the most widely used
tools for blocking TGFf3. To my knowl dge, no studies
have been designed that spe ifically block laminin synthesis
in experimental models of renal di ase, because this
matrix protein has not been considered as pat ophysiologi-
cally relev nt as collagens or fibronectin. The interesting
observations from Abrass and colleagues demonstrating
the acc mulati n of laminin in the glomerular basement
embrane of old rats suggest hat this extraceflular protein
plays a role in th  genesis of the a ing-related renal
changes [19]. In consequence, experiments dir cted at
spe ifically blocking particu r laminin isoforms could pro-
'ide interesting information regarding the mechani ms
in olved in the a ing process.
DR. ANGEL DE FRANCISCO (Professor of Nephrolo.', Uni-
versity Hospital "MarquEs tie Valdecilla," Santander, Spain):
I have a question oncerning t  hemodynamic actions of
ACE nhibitors in a ing. A ing is accompanied by renal
vasocons riction. Taking into account the importance of
angiotensin II in th  regulati n of renal blood flow, d  you
believe hat ACE nhibitors could be useful in preventing
the a ing-related reductio  in renal blood flow?
DR. oDRIGuEz-Pu\oL: The importance of angiote sin
II in the a ing-r lat  reduction i  renal blood flow reduc-
tion is not known. Different xperimental approaches, such
as measuring the circulating levels of renin or angiote sin
U or measuring the angiotensin II turnover, have provided
conflicting results [39—41, 3, 64]. The conflicting re ults
arc n t too surprising, as the critical question—the degree
of activati n of the local reni -angiote sin ystem— cannot
be directly explored. When ACE nhibitors are used to
block the synthesis of angiotensin II, renal plasma flow in
older rats incr ases [64], thus suggesting h , at least
p rtially, renal vasocons riction may depend on incr ased
local synthesis of angiote sin I! in rats. Young and old
human beings show a comparabl  hemodynamic response
to angiotensin II blockade [54, 64].
DR. MANUEL ARIAS (Head, Nephr logy Department, Uni-
ve,:sity Hospital "MarquEs de Valdecilla": We have some data
in patients with advanced chronic ren l failure showing a
predominance of FAS an  a d cr ment of bcl-2,  pattern
of incr ased programmed cell death. D  you have any
xperi nce in the analysis of renal tissue for the ap ptosis
genes? D  you think hat ap ptosis might be responsible
for a ing of the kidney?
D . ODRIG Ez-PuYoL: That is a very interesting ques-
tion. We have considered t e hypothesis hat a change in
the ap ptosis rate is  pathogenetic mechanism in the a ing
kidney. Using Northern blot analysis,  were unable to
detect changes in the mRNA expressi n of bcl-2, whereas
bax slightly hut s gnificantly d cr ased in the renal cortex
from old rats. However, these results are preliminary and
incomplete, as hcl-2/b x are not the only th  genes in olved
in th  regulation of a optosis. Additional studies are
n eded to adequately answer your question.
DR. JosÉ M RIA MORALES Assistant Prof èssor of Medi-
cine, Hospital "12 de Octubre, "Madrid, Spain): Do you have
information regarding cycl sporine's nephrotoxic ty in ag-
ing kidneys?
Dg. RODR1GUEZ-PUYOL: As I said earlier, our group
believes that reactive oxygen speci s seem to be in olved in
the pathogenesis of a ing-related renal changes. M reover,
we have recently demonstrated hat cycl sporine A in-
cr ases the synthesis of ROS by cultured human mesangial
cells [105]. In cons qu nce, it is possible that cycl sporine
A is mor  nephrotoxic in the lderly. The influ nce of age
in cycl sporine A-induced nephrotoxicity has been studied
in rats [106], bu  r ts are not a good model for analyzing
cycl sporine-induced d mag  because the dose hat must
be used to induce renal d mage is much igher than the
usual doses in human beings (50 m kg/day). In patients
receiving a renal graft, cycl sporine A nephrotoxity does
not seem to be incr ased w th increasing donor age [107].
To my knowl dge, however, no clinical studies hav  been
designed to answer this question spe ifically. These studies
should b  pe formed in patients with heart, live , or lung
transplants. or in patients receiving cycl sporine because of
extrarenal di ases.
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DR. JAVTER DIEZ (Professor of Medicine, Head, Vascular
Pathophysiologv Unit, University of Navarra, Pa,nplona,
Spain): Frohlich and colleagues have shown that blockade
of the endothelial constitutive nitric oxide synthase in
young SHR rats causes morphologic and functional renal
changes similar to those present in untreated, old SHR rats
[108). This group also demonstrated that ACE inhibitors
can prevent these renal changes. Can hypertension accel-
erate the aging process by amplifying the alterations due to
diminished nitric oxide availability? Is there a role for ACE
inhibitors in preventing renal aging in hypertensive pa-
tients?
DR. RODR1GUEZ-PUYOL: I have tried to communicate my
particular point of view, which is that aging is an evolution-
ary process in which the equilibrium between the deleteri-
ous vasoconstrictor/profibrotic local mediators and the
beneficial vasodilator/antifibrotic autacoids is progressively
displaced towards the former. For instance, nitric oxide
could counterbalance the effects of angiotensin II for long
periods, until the nitric oxide system fails and renal dys-
function develops. If this hypothesis were right, the answers
to your two questions would be yes. Hypertension, by
inducing endothelial dysfunction, could decrease the activ-
ity of NOS-3, and subsequently accelerate renal aging. On
the other hand, the decreased local concentration of angio-
tensin II that occurs after ACE inhibitor treatment could
slow the aging process. But as I said, neither the exact role
of angiotensin II nor the nature of the changes in the nitric
oxide system has been adequately clarified in the pathogen.
esis of aging in the kidneys. More studies are needed.
DR. M.ruEL. PiG (Assistant Professor of Medicine,
Hospital "12 de Octubre"): As you know, several studies
have shown that ACE inhibitors can slow the progression of
renal disease in different clinical settings [109]. However,
patients over 65-70 years old generally have been excluded
from these studies. Do you think that ACE inhibitors also
could slow the progression of the age-related decline in
renal function?
DR. R0DR1GuEz-PUY0L: We believe that ACE inhibitors
can slow the progressive decline of renal function in the
elderly. Our own results in rats, which have been presented
previously [201, support this contention. However, no stud-
ies in elderly human beings (older than 65—70 years) have
been performed. It would be very interesting to analyze, on
a long-term basis, the role of ACE inhibitors on the
progression of aging-related renal changes.
Di. CARLOS QUEREDA (Chief, Clinical Section of Nephrol-
ogy, University Hospital "Ramôn y Cajal," Madrid): As the
kidneys are mainly vascular organs, to what extent do you
think that aging-related functional changes depend on
structural vascular damage? In other words, do you believe
that most of the renal dysfunction is a consequence of
arteriosclerosis?
DR. RODR1GUEZ-PUYOL: That very interesting question
was specifically addressed some years ago [221. Although it
is difficult to separate intrinsic renal damage from the
vascular process in patients with severe vascular disease,
renal dysfunction cannot be solely explained by structural
arterial changes in older healthy humans. Several investi-
gations have demonstrated that the renal circulation in
older individuals has characteristic patterns of response to
the administration of different drugs. These responses were
defective when compared to those in young subjects, and I
do not believe that the differences can he explained by
arteriosclerotic damage [22, 24, 54].
DR. ARMANDO TORRES (Professor of Nephrology, Univer-
sity Hospital, Tenerife, Spain): Insertion-deletion polymor-
phism of the ACE might contribute to progression of
chronic renal failure. As you mentioned, about 30% of
older individuals do not have an age-related decrease in
GFR. Has any evidence disclosed an association between
ACE polymorphism and an age-related decrease in GFR?
DR. RODR1GUEZ-PUYOL: The lack of renal dysfunction in
a substantial minority of the aged population has been
explained by different mechanisms. It has been attributed
to environmental differences and to the absence of any
overt renal disease. Obviously, genetic factors would be
important; in this sense, ACE polymorphism could be
involved. Unfortunately, this hypothesis has not been tested
yet.
DR. NELIDA ELENO 4ssociate Professor, Department of
Physiology', University of Saiwnanca, Spain): Did you try to
give antioxidant treatment to those od rats that you
presented in your talk?
DR. RODR1GUEZ-PUYOL: We tried to determine whether
vitamin E could block the expression of the TGFp mRNA
in the renal cortex of older rats, but we did not obtain
conclusive results. We are now working with taurine, an
amino acid with antioxidant properties. It seems that
taurine could block the mRNA expression of some collagen
types in the renal cortex. However, these results are very
preliminary.
DR. MANUEL MART1NEZ-MALDONADO (Professor of Medi-
cine, Emoiy University, Atlanta, Georgia, USA): Data sug-
gest a beneficial effect of ACE inhibitors in reducing the
aging-related morphologic and functional renal alterations
in rats [1101. Are there studies of a similar nature, or
studies examining other functional aspects, such as urine
concentration and dilution, in humans? What is the effect
of nutrients on renal function as aging proceeds? Could this
be the reason patients were separated into three groups in
the Baltimore aging study 281?
DR. RODR1GUEZ-PUYOL: Unfortunately, there are no def-
inite answers for your questions. The ability of ACE
inhibitors to prevent the aging-related morphologic and
functional renal changes has not been tested in long-term
studies in humans. With respect to the ability of ACE
inhibitors to modify the non-hemodynamic, non-glomeru-
lar alterations that characterize renal aging in men, no data
are available. ACE inhibitors might prevent interstitia'
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DR. JAVTER DIEZ (Profess r of Medicine, Head, Vascular
Pathophysiology Unit, University of Nav rra, Pa,nplona,
Spain): Frohlich and colleagues have shown that blockade
of the endothelial consti utive n tric oxide synthase in
young SHR rats cau es morph logic and functional renal
changes similar o those pr sent in untreated, old SHR rats
[108). This group also demonstrated that ACE inhibitors
can pr vent th s  renal changes. Can hyp rtension accel-
era e the aging process by amplifying the alterations due to
diminished n tric oxide v ilability? Is there a role for ACE
inhibitors in pr ve ting ren l aging in hypertensive pa-
tients?
D . RODR1GUEZ-PUYOL: I have ried t  communicate my
particular point of view, which is th t aging is an evolution-
ary process in whic  the equilibrium between the deleteri-
ous vas constrictor/profibrotic local mediators and the
b neficial vasodilator/antifibrotic autacoid is progressively
displaced towards the former. For instance, n tric oxide
could counterbalance the effects of angiotensin II for long
periods, until the n tric oxide ystem fails and renal dys-
function d velops. If this hypothesis we e right, the answers
to your two questions would be yes. Hypertension, by
inducing endothe ial dysfunction, could decrease the activ-
ity of NOS-3, and subsequently accelerat  ren l aging. On
the other hand, the decreased local concentration of angio-
tensin II that occurs after ACE inhibito  treatment could
slow the aging process. But as I said, neither the exact role
of angiotensin II nor the nature of the changes in the n tric
oxide ystem has been adequately clarified in the pathogen-
esis of aging in the kidneys. More studies are ne ed.
DR. M uei  RAG (A sistant Profess r of Medicine,
Hospital "12 de Octubre"): As you know, s veral studies
have shown that ACE inhibitors can slow the progression of
renal disease in different clinical settings [109]. How ver,
patients over 65-70 years old g nerally have been exclu ed
from th e studies. Do you think that ACE inhibitors also
could slow the progression of the age-related decline in
renal function?
D . R0DRIGuEz-PUY0L: We b li ve that ACE inhibitors
can slow the progressive decline of renal functio  in the
elderly. Our own results in rats, which have been pr sented
previously [20], support this contention. How ver, no stud-
ies in elderly human beings (older than 65—70 years) have
been performed. It would be very interesting to nalyze, on
a long-term basis, the role of ACE inh bitors on the
progression of aging-related renal changes.
Di. CARLOS QU REDA (Chief; Clinical Section of Nephrol-
ogy, University Hospital "RamOn y Cajal," Ma rid): As the
kidneys are mainly vascular organs, to what extent do you
think th t aging-related functional changes d pend on
structural vascular damage? In other words, do you b li ve
that most of the renal dysfunction is a consequence of
a teriosclerosis?
D. o I - L: That very int resting question
was specifically addressed some years ago [221. Although it
is d fficult to sep rate intrinsic renal damage from the
vascular process in patients with s v re vascular disease,
renal dysfunction cannot be solely explained by structural
arterial changes in older healthy humans. S veral investi-
gations have demonstrated that the renal circulatio  in
older individuals has character stic patterns of response to
the administration of different drugs. Th s  respon es were
defective when compared o those in young subjects, and I
do not b li ve that the diff rences can he explained by
arteriosclerotic damage [2 , 24, 54].
DR. ARMANDO TORRES (Profess r of Nephr logy, Univer-
sity Hospital, T nerife, Spain): Insertion-deletion polymor-
phism of the ACE might contribute to progression of
chronic renal failure. As you mentioned, about 30% of
older individuals do not have an age-relate  decrease in
GFR. Has any evidence disclosed an assoc ation between
ACE polymorphism and an age-related decrease in GFR?
D . R0DRIGUEz-PuyoL: The f renal dysfunction in
a substantial minority of the aged opulation has been
explained by diff rent mechanisms. It has been attributed
to environmental diff rences and to the absence of any
ove t renal disease. Obviously, g netic factors would be
important; in this sense, ACE polymorphism could be
involved. Unfortunately, this hypothesis has not been tested
yet.
DR. NELIDA ELENO 4ssociat  Professor, Department of
Physiology, University of Salanianca, Spain): Did you try to
give antioxidant treatment to those old ra s that you
pr sented in your talk?
D . RODR1GUEZ-PUYOL: We rie to determine whether
vitamin E could block the expressi n of the TGF mRNA
in the renal cortex of older rats, but we id n t obtain
conclusiv  results. We are no  working with taurine, an
amino acid with antioxidant properties. It seems that
taurine could block the mRNA expression of some collagen
types in th  renal cortex. How ver, th s  results are very
preliminary.
DR. MANUEL MART1NEZ-MALDONADO (Profess r of Medi-
cine, Emoiy University, Atlanta, Georgia, USA): Data sug-
gest a b neficial ffect of ACE inhibitors in reducing the
aging-related morph logic and functional ren  alterations
in rats [1 01. Are there studies of a similar nature, or
studies exami ing other function l aspect , such as urine
concentration and dilution, in humans? What is the effect
of nutrients on renal function s aging proceeds? Could this
be th  reason patients w re sep rated into three groups in
the Baltimore aging study [281?
DR. R0DRIGUEz-PuyoL: Unfortunately, th re are no def-
nite answers for your questions. The ability of ACE
inhibitors to pr vent the aging-related morph logic and
functional renal changes has not been tested in long-term
studies in humans. With respect to the ability of ACE
inhibitors to modify the on-hemodynamic, on-glomeru-
l r alterations that characteriz  ren l aging in me , no data
are v ilable. ACE inhibitors might pr vent interstitial
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fibrosis in aging rats. Likewise, these agents might improve
tubular function in humans, but the functional improve-
ment would be very difficult to distinguish from the hemo-
dynamic modifications. Finally, one of the possible expla-
nations for the existence of three different groups in the
Baltimore study could be diet, but other afternatives exist,
as I said before.
Dj. FRANCISCO ORTEGA (Head, Health-Related Quality of
Life Unit, Hospital central de Asturias, and Nephrotogy
Research Instiri.ae "Reina Sofia, ' Oviedo, Spain): In our
studies, patients over 65 years undergoing chronic hemodi-
alysis had a worse quality of life than did those in the
normal population randorny selected, but elderly patients
with a functioning kidney graft had a similar quality of 'ife,
even better in some dimensions, than this normal popula-
tion [Ill]. Do you think that a functioning kidney trans-
plant caji delay the consequences of general aging on
quality of life?
Dg. R0DRiGUEz-PuY0L: I am not familiar with your data
on quality of life, but I do not believe that renal transplan-
tation specifically de'ays the consequences of aging. I
believe that a renal graft improves the quality of life in
every patient, including the elderly, in such a significant way
that usual quality-of-life tests cannot detect significant
differences between the grafted and normal populations.
DR. ALBERTO MARTINEZ-CASTELAO (Chief, Dialysis Divi-
sion, Bellvi:ge c.S. U.B., Barcelona, Spain): In our experi-
ence. more than 50% of patients with nonsteroidal antiin-
flammatory drug nephrotoxicity are diagnosed after age 65.
Do you have any evidence that relates ROl overproduction
with this increased sensitivity?
DR. RODR1GUEZ-PUYOL: To my knowledge, nonsteroidal
antiinflammatory drugs do not induce ROl overproduction.
En fact, cyclo-oxygenase and lipoxygenase activation might
be linked to ROl synthesis. The deleterious effect of these
agents in elderly individuals must be due, as in other renal
diseases, to the importance of arachidonic acid derivatives
in the maintenance of renal function.
DR. FERNANDO VALDERRABANO (Professor of Medicine,
University Hospital "Gregorio Marañón," Madrid): Diego,
congratulations for your excellent review. Nowadays, we
frequently transplant organs from donors older than 65 to
young patients. Is there any evidence regarding changes in
the process of aging in these cases?
DR. RODRIGUEZ-PUYOL: Transplantation of old kidneys
into young patients could be a very interesting model for
analyzing the relative importance of genetic and ambient
factors in the development of aging-related renal changes.
This question has not been systematically considered, and I
beHeve that taking into account the complex situation of
the transplant recipient. it will be very difficult to reach
significant conclusions from these kind of grafts.
DR. SANTOS CAsADO (Head. Nephrok Department, Fun-
dación Jirnénez DIaz. Mad,id): Dr. RodrIguez-Puyol, in your
presentation. you mentioned that ROl and different cvtO-
kines could be involved in the genesis of the renal changes
that characterize aging. You also reviewed the role of
endothelial constitutive NOS and endothelin. Did you test
iNOS expression?
DR. R0DRIGuEz-PuY0L: No, we have not tested iNOS
expression in aging kidneys. However, we believe that this
NOS isoform must be involved in the aging process, at least
in the development of the functional changes, aUhough we
are not sure about the relationships between iNOS and
aging. One of the first demonstrations of aging-related
impaired renal vasodilatlon was performed in rats treated
with pyrogen [1313 and it is now a welt-recognized fact that
some of the components of pyrogen induce iNOS expres-
sion.
DR. DIEz: Diego, at the vascular level, one of the most
important sources of ROl is the NADP-NADPH oxidase
system. An overproduction of ROl has been reported in the
aorta from spontaneously hypertensive rats [1121. Havc you
any information concerning possible alterations in the
expression of this enzyme in the kidneys from old normo-
tensive rats?
DR. R0DRIGuEz-PuYol.: We have not performed this kind
of analysis and, to my knowledge, this specific information
has not been published. But it would be very interesting to
analyze the NADP-NADPH oxidase system in aging, as
some vasoactive factors, particularly angiotensin II, stimu-
late ROl synthesis by activating this system. The NADP-
NADPH oxidase system could constitute the link between
an increased synthesis of local mediators and ROl overpro-
duction.
DR. Juuo PAscui (Division of Nephro!og Hospital
"Ramón y Cajal," Madrid): Looking at aging as a slowly
progressive death process, do you think that ROl play a
relevant role in high morbidity-mortality conditions such as
acute renal failure with multiorgan failure, or even chronic
dialysis in elderly patients?
DR. RODRIGUEZ-PUYOL: From a theoretical point of view,
the answer is yes. Reactive oxygen intermediates might be
increased in the patients that you have mentioned, and
aging could increase local synthesis of these mediators.
However, the Madrid Acute Renal Failure Study Group
determined the prognosis of acute renal failure in older
patients to be similar to that in younger patients [1131;
these data suggest that age is not a particularly poor
prognostic sign.
DR. HARRINGTON: Let me ask the last question. The
patients you presented both had iatrogenic renal problems.
How should we deal with our increasing aging population
to prevent the type of problems seen in your patients?
DR. RODRIGuEz-PuYOL: If you consider the two patients
whom I presented, the problems began in two different
settings. In the second case, nephrotoxic drugs were pre-
scribed by genera' physicians on an outpatient basis. Gen-
eral physicians must be extensively and repeatedly in-
formed about the potential nephrotoxicity of three kinds of
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fibrosis in aging rats. Likewise, these agents might improve
tubular function in humans, but he functional improve-
ment would be very difficult o distinguish from the hemo-
dynamic modifications. Finally, one of the pos ible expla-
nations for the existence of thre  different groups in the
Baltimore study could be diet, but other afternatives exist,
as I said before.
Dj. FRANCISCO ORTEGA (Head, Health-Related Quality of
Life Unit, Hospital central de Asturias, and Nephrotogy
Research Instiri.ae "Reina Sofia, ' Oviedo, Spain): In our
studies, patients over 65 years undergoing chronic hemodi-
alysis had a worse quality of life than did those in the
normal population randorny selected, but elderly patients
with a functioning kidney graft had a similar quality of 'ife,
even better in some dimensions, than this normal popula-
non [Ill]. Do you think that a functioning kidney trans-
plant caji delay the consequences of general aging on
quality of life?
Dg. R0DRiGUEz-PuvoL: I am not famil ar with your data
on quality of life, but I do not believe that renal transplan-
tation specifically de'ays the consequences of aging. I
believe that a renal graft improves the quality of life in
every patient, including the elderly, in such a significant way
that usual quality-of-life tests can ot detect significant
differences betwe n the grafted and normal populations.
DR. ALBERTO MARTINEZ-CASTELAO (Chief, Dialysi Divi-
sion, Bellvi:ge c.S. U.B., Barcelona, Spain): In our experi-
eiice. more than 50% of patients with nonsteroidal antiin-
flammatory drug nephrotoxicity are diagnosed after age 65.
Do you have any evidence that relates ROl overproduction
with this increased sensit vity?
DR. RODR1GUEZ-PUYOL: To my knowledge, nonsteroidal
antiinflammatory drugs do not induce ROl overproduction.
En fact, cyclo-oxygenase and lipoxygenase activation might
be linked to ROl synthesis. The deleterious effect of these
agents in elderly individuals must be due, as in other renal
diseases, to the importance of arachidonic acid derivatives
in the maintenance of renal function.
DR. FERNANDO VALDER ABANO (Professor of Medicine,
University Hospital "Gregorio Marañón," Madrid): Diego,
congratulations for your excellent review. Nowadays, we
frequently transplant organs from donors older than 65 to
young patients. Is there any evidence regarding changes in
the proces  of aging in these cases?
DR. RODRIGUEZ-PUYOL: Transplantation of old kidneys
into young patients could be a very interesting model for
analyzing the relative importance of genetic and ambient
factors in the development of aging-related renal changes.
This question has not be n systematically considered, and I
beHeve that aking into ac ount he complex situation of
the transplant recipient. it will be very difficult o reach
significant conclusions from these kind of grafts.
DR. SANTOS CAsADO (Head. Nephrok Department, Fun-
dación Jirnénez DIaz. Mad,id): Dr. RodrIguez-Puyol, in your
presentation. you mentioned that ROl and dif erent cvto-
kines could be involved in the genesis of the renal changes
that characterize aging. You also reviewed the role of
endothelial consti utive NOS and endothelin. Did you test
iNOS expres ion?
DR. R0DRIGuEz-PUY0L: No, we have not tested iNOS
expres ion in aging kidneys. However, we believe that his
NOS isoform must be involved in the aging proces , at least
in the development of the functional changes, aUhough we
are not sure about he relationships betwe n iNOS and
aging. One of the first demonstrations of aging-related
impaired renal vasodilatlon was performed in rats treated
with pyrogen [1313 and it is now a welt-recognized fact hat
some of the components of pyrogen induce iNOS expres-
sion.
DR. DIEz: Diego, at he vascular level, one of the most
important sources of ROl is the NADP-NADPH oxidase
system. An overproduction of ROl has be n reported in the
aorta from spontaneously hypertensive rats [1 21. Havc you
any information concerning pos ible alterations in the
expres ion of this enzyme in the kidneys from old normo-
tensive rats?
DR. R0DRIGuEz-PuYo1.: We have not performed this kind
of analysis and, to my knowledge, this specific information
has not be n published. But it would be very interesting to
analyze the NADP-NADPH oxidase system in aging, as
some vasoactive factors, particularly angiotensin II, stimu-
late ROl synthesis by activating this system. The NADP-
NADPH oxidase system could consti ute the link betwe n
an increased synthesis of local mediators and ROl overpro-
duction.
DR. Ju o PAScUAL (Division of ! g ospital
"Ramón y Cajal," Madrid): Lo king at aging as a slowly
progres ive death proces , do you think that ROl play a
relevant role in high morbidity-mortality condit ons such as
acute renal failure with multiorgan failure, or even chronic
dialysis in elderly patients?
DR. RODRIGUEZ-PUYOL: From a theoretical point of view,
the answer is yes. Reactive oxygen intermediates might be
increased in the patients that you have mentioned, and
aging could increase local synthesis of these mediators.
However, the Madrid Acute Renal Failure Study Group
determined the prognosis of acute renal failure in older
patients to be similar to that in younger patients [1 31;
these data sug est that age is not a particularly po r
prognostic sign.
DR. RINGTON: Let me ask the last . The
patients you presented both had iatrogenic renal problems.
How should we deal with our increasing aging population
to prevent he type of problems se n in your patients?
DR. R0DRIGuEz-PuYoL: If you consider the two patients
whom I presented, the problems began in two dif erent
settings. In the second case, nephrotoxic drugs were pre-
scribed by genera' physicians on an outpatient basis. Gen-
eral physicians must be extensively and repeatedly in-
formed about he potential nephrotoxicity of thre  kinds of
262 Nephroiogy Forum: The agi g kidney
f brosis  aging rats. L k wise, these agents might improve
tubular function in humans, ut the functional improve-
ment would he very difficult to distinguish from the hemo-
dyna ic modif cations. Finally, one of the possible expla-
nations for the xist nce of three different groups in the
Baltimore study coul  b diet, hut oth  al ernatives exist,
as I said before.
Dj. FRANCISCO ORTEGA ( ead, Health-Related Quality of
Life Unit, Hospital Central de Asturias, and Nephrolo'
Research Institute "Reina Sofia," Oviedo, Spai ): In our
studies, pa ients over 65 years under oing chronic hemodi-
alysis h d a worse quality of life than did those in the
normal population ra domly s lected, but elderly pa ients
with a fu ctioning kidney gr ft h d a similar quality of life,
even better in some dimensions, t an this normal popula-
tion [111]. Do you ink that a fu ction ng kidney trans-
plant can delay the consequences of general a i g on
quality of life?
D. oDRIGuEz-PuvoL: I am not f miliar with your dat
on quality of life, hut I d  not b lieve that renal transplan-
tation spe ifically delays the cons qu nces of a ing. I
believe that a ren l graft improv s the quality of l fe in
every pa e t, including th  e derly, in such a s gnificant way
that usual quality-o -life tests cannot detect s gnificant
differ nces b twe n the grafted a d normal populations.
DR. ALBERTO MARTINEZ-CASTELAO (Chief D alys s Divi-
sion, Bellvi:ge CS. (lB., Barcelona, i ): I  our e
nce. more than 50% of patien s with nonsteroidal a tiin-
fi mmatory drug nephrotoxicity are diagnosed aft r age 65.
Do you have any evid nce th  r lates ROl overproduction
with this increas d ensitivity?
DR. R0DRIG EZ-PUYOL: To my knowledge, n nsteroidal
a tiinfi mmatoiy drugs d  ot induce ROl overproduction.
En fact, cyclo-oxygen se and lipoxygen se c vation might
be linked to ROl synthesis. Th  d leterious effect of these
agents in elderly in ividual  must be due, as in oth r renal
dis ases, to the importance of arachidon c acid der atives
in the maintenance of renal fu ction.
D . FER ANDO VALDERRABANO (Pr fessor of Medicine,
Un versity Hospital "Gregorio Marañón," Madrid): Diego,
congr tulati ns for your xcell nt review. Nowadays, we
fr quen ly transplant organs from don rs older than 65 to
young pa ients. Is there any evid nce regarding changes in
the process of a i g in the  cases?
DR. ODRIGUEZ-PUYOL: Tr splantation of ol  kidneys
int  young patients could b  a very in eresting model for
analyzing the relative importance of genetic nd ambient
factors in the development of a ing-r lat d ren l changes.
This question has not been system ti ally consi ered, and I
believe h t taking into account the complex s uati n of
the transplant r cipient, it will he very difficult to reach
s gnifi a t onclusions from these kind o  grafts.
DR. SANTOS CASADO (Head. Nephrolo Department, Fun-
dac ón Jinienez DIaz. Madrid): Dr. RodrIguez-Puyol, in your
presentati n. you me tioned that ROl and different cyto-
kines could be in olved in the genesis of the ren l changes
t t characterize a ing. You also r vi wed the r le of
endothelial cons tutive NOS and endothel n. Did you test
iNOS xpression?
D . R0DRIGUEz-PUY0L: No, we have not tested iNOS
xpression  a ing kidneys. Howev r, we b lieve t at this
NOS isoform must be involved in the aging process,  least
in the development o the fu ction l changes, alt ough we
are not sure about the relation hips b tween iNOS and
a ing. One of the first demonstrati ns of a ing-r lated
impaired ren l vasodilation was performed in rats treated
with pyrogen [131, and it is no  a well-recognized fact that
s me of the c mponents of pyrogen induce iNOS xpres-
sion.
R. DIEz: Diego, at the vascu ar level, ne of the most
important sources of ROl is the NADP-NADPH oxidase
system. An overproduction of ROl has b n reported in the
orta from spontaneously hypertensive rats [ 121. Have you
any informati  o cerning possibl  lteratio s in the
xpressi n of this enzyme in the kidneys fr m ld normo-
tensive rats?
DR. ODR1GUEZ-PuY0L: We have not performed this kind
of analysis and, to my knowl dge, this spe ific information
has not been published. But it would be very in eres ing to
analyz  the NADP-NADPH oxidase system in a ing, as
some v soactive factors, particul rly angiotensin II, stimu-
late ROl synthesis by ctiva ing this system. The NADP-
NADPH oxida e system could cons itut the link b tween
an increased synthesis f local mediators and ROl overpro-
duction.
DR. Juuo PAscuAI (D vision of Nephro!og Hospital
"Ramón y ('ajal," Ma rid): Looking at a ing  a slowly
p ogressiv  death process, d you think that ROl pl y a
relevant role n igh morbidity-mortality conditions such as
acute ren l failure with multiorg n failu e, or even chronic
d alysis in elderly pa ients?
DR. ODR1GUEZ-PUYOL: From a theoretical point of view,
the answer is y s. Reactive oxygen int rm diates might be
incr ased in the patients that you have mentioned, and
a ing could incr ase local synthesis of thes  mediators.
However, the Madrid Acut  Rena  Failure Study Group
determined the progn sis of acute ren l failure in older
patients to be similar to hat in younger patients [ 31;
these data sugges  hat age is not  particularly poor
pr gnost c sign.
DR. HARRI GTON: L t me ask the last question. The
pa ients you presented both h d iatrogenic renal problems.
How should we deal with ou  increasing a ing population
to prevent th  type f problems seen in your patients?
DR. 0DRIGUEz-PuY0L: If you consider he two pa ients
whom I presented, the problems began in two different
settings. In the second cas , ncphrotoxic drugs were pre-
scri ed by general physicians on an outpatient basis. Gen-
eral physicians must be xtensively and rep atedly in-
formed about th  pote tial nephrotoxicity of three kinds of
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drugs. nonsteroida antiinflammatorv drugs, ACE inhibi-
tors, and diuretics. particularly if they are prescribed to-
gether. Within the hospital, as was the case with the first
patient. the probkm is more comp'ex. The situation of the
patient is more critical, more potentially nephrotoxic drugs
are used, and intravenous fluid therapy frequently is
needed. In addition to adequate monitoring of the extra-
cellular volume status and biochemical parameters, as well
as to judicious use of drugs and fluids, early contact with the
nephrology team may avoid unnecessary complications.
Reprint requests to Di B. Rodriguez-Puyo!. chief Vephro!ogv Section,
Hospücd 'PrIncipc de Asrurias, " Alcalá de Henares, 2&'O5 !!adr4 Spain
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drugs. onsteroidal a tiinflammatorv drugs. ACE nhibi-
tors, and diuretics. particu arly if they are prescribed to-
g ther. W thin t e hospit l, as was the case wi  the first
patient. the problem is more complex. The situation of the
patient is more critical, more po entially nephrotoxic drugs
are used, and intravenous fluid therapy frequently is
ne ed. In addition to adequate monitoring of the extra-
ce lular volume status and biochemical parameters, as well
as to judicio  use of drugs and fluids, early con act wit  the
nephrology tea  m y avoid unnecessary complications.
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